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Co-transmission in vascular smooth muscle was examined with a view to 
establishing the nature and mechanism of action, of each of the 
transmitter substances released in response to nerve stimulation.
1. The intracellularly-recorded electrical and simultaneous 
mechanical responses of the rabbit saphenous artery were examined in 
vitro in response to field stimulation of intramural sympathetic 
nerves and to exogenously applied drugs.
2. In the rabbit saphenous artery the resting membrane potential was 
-69.39 ± 0.26mV (n=250), the space constant (\  ) was 0.42 ± 0.12mm
(n=12). Field stimulation evoked excitatory junction potentials 
(e.j.p.s), which facilitated (>lHz) and summated (>2Hz). These e.j.p.s 
were abolished by infusion of a,0-methylene ATP (ap MeATP 10“^M), but 
were unaffected by prazosin (10“^M), suggesting that they were 
mediated by an ATP-like substance. There was no additional electrical 
event which was associated with NA, implying that NA does not evoke a 
significant voltage-dependent response in this artery and may act via 
a voltage-independent mechanism.
3. Exogenous application of ATP (10-^M) or its stable analogue ap 
MeATP (10“^M) by close pressure ejection from a micro-pipette, 
produced dose dependent depolarisations. NA (10“^M) similarly applied 
was ineffective. Theses results are consistent with the view that the 
transmitter substances, NA and ATP (or a closely related substance), 
released from the rabbit saphenous artery produce dissimilar 
electrical effects.
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4. Action potentials were not observed in the absence of drugs in the 
rabbit saphenous artery. In the presence of tetraethylammonium (TEA, 
5xl0“^-10“% )  however, action potentials were observed in response to 
both single stimuli and trains of pulses. This suggested that action 
potentials are normally absent in this tissue as a result of a fast 
rectifying K+-current, but can be sustained when this conductance is 
inhibited.
5. Alteration of the external ionic environment by changing [K+ ]0 , 
[Na+ ]0 and [Cl” ]0 suggested that changes in K+ and Na+ conductance may 
underlie the e.j.p. produced by nerve-released ATP.
6. In the rabbit saphenous artery, approximately 50% of the 
contraction was abolished by ap MeATP (10”% ) ,  while the remainder was 
abolished by prazosin (10“% ) .  Both NA and ATP therefore contribute to 
the mechanical event, supporting their co-transmitter role in this 
tissue.
7. All electrical and mechanical responses were abolished by either 
tetrodotoxin (TTX, 10“% )  or guanethidine (10“% ) ,  indicating that 
they were due to transmitters released from the same sympathetic 
nerves. Idazoxan (10”% )  enhanced both the electrical and mechanical 
responses, suggesting that a 2 -adrenoceptors can pre-junctionally 
modulate release of both transmitters. This supports the view that 
both ATP and NA are released from the same nerves.
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8. The P2 X-purinoceptor desensitising agent ap MeATP was shown to be 
a suitable selective compound for analysis of the ATP component of 
co-transmission in the rabbit saphenous artery. No evidence was 
obtained from examination of the effect of ap MeATP (10“^-4xl0“% )  on 
membrane conductance by the method of Abe & Tomita (1968) for a 
non-selective membrane effect of this compound, nor were any 
differences between the effect of ap MeATP on the evoked e.j.p.s and 
on the response to exogenously added ATP observed, ap MeATP did not 
alter the contractions evoked by NA( 10~^-10“% ) , by histamine 
(10"6“10“4M) or by the post-junctional actions of KCl (1-1.6x10“% ) .
9. Suramin abolished evoked e.j.p.s and attenuated the contraction 
evoked by ATP (10“^-10“% )  and ap MeATP (10”^-10“% )  without affecting 
the contraction to NA (10”^-10“% )  or the post-junctionally evoked 
contractions to KCl (10“^-1. 6x10“% ) .  It however attenuated the 
contractions to histamine (10“^-10“4M) and 5-hydroxytryptamine (5-HT, 
10“k-10“4M) and thus seemed less selective as an antagonist of 
P 2 ~purinoceptors in the rabbit saphenous artery.
10. NA failed, in the rabbit saphenous artery, to evoke hydrolysis of 
phosphatidylinositol 4,5-bisphosphate (PIP2 ), as measured by 
incorporation of myo- [ 2 - % ]  -inositol into the water soluble 
metabolites of PIP2  hydrolysis - the inositol phosphates. This was the 
case even in the presence of propranolol (3xl0“% )  to inhibit any 
inhibitory effect of p-adrenoceptors on PIP2 hydrolysis. In the rat 
tail however, used as a positive control, NA produced a dose dependent
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hydrolysis of PIP2 * This implies that PIP2 hydrolysis is not the basis 
for the voltage-independent mechanism by which NA produces contraction 
in the rabbit saphenous artery.
11. Since ap MeATP (10”% )  and histamine (3xl0”% )  but not KCl 
(8xl0“% )  each evoked hydrolysis of PIP2  in the rabbit saphenous 
artery, the mechanism for this hydrolysis exists in this tissue, but 
was clearly not utilised by NA.
12. The phorbol ester, phorbol 1,2-myristate 1,3-acetate (PMA, 
10”®-10“% )  enhanced the contractile responses to exogenous NA 
(10”^-10“% )  and to field stimulation (0.5ms, supramaximal voltage, 
l-32Hz). The post-junctionally evoked contractions to exogenously 
added KCl (10“^-l. 6x10”% )  were unaffected. This suggested that 
protein kinase C (PKC) and the production of diacylglycerol (DAG) were 
involved in the contraction to NA.
13. Mepacrine (3xl0”% )  did not alter the contraction to NA 
(10"7-10“4M ) , while sodium oleate (NaOl, 2x10“% )  enhanced and sodium 
fluoride (NaF, 5x10”% ) )  attenuated the contraction to these doses of 
NA, suggesting that in the rabbit saphenous artery, phospholipase D 
(PLD), but not phospholipase A 2 (PLA2 ) may be an involved in the 
contraction to NA.
14. In the rabbit saphenous artery, NA evoked a dose dependent 
increase in hydrolysis of phosphatidylcholine (PC) as measured by 
incorporation of %-methyl choline chloride into the water soluble
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metabolites choline (Cho) and choline phosphate (ChoP). Increased 
levels of Cho implicated phospholipase D (PLD) in the hydrolysis of 
PC, while a smaller rise in the levels of ChoP implied that 
phospholipase C (PLC) was involved to a lesser extent. Levels of a 
third possible metabolite, glycerophosphocholine (GPC), the presence 
of which would indicate an action of phospholipase A 2  on PC, were 
unaffected by NA.
15. ap MeATP (10~^-10_4M) and histamine (10-^-10-4M) each stimulated 
hydrolysis of PC resulting in raised levels of Cho and ChoP but not 
GPC. The increased levels of Cho and ChoP evoked, suggest that ap 
MeATP utilises PLC and PLD approximately equally in the hydrolysis of 
PC while histamine predominantly utilises PLC.
16. A combination of ap MeATP and NA, (each 10_^-10_4M ) , evoked no 
greater a rise in levels of Cho, than did ap MeATP alone. Increased 
levels of ChoP produced by the combination of these agonists were 
however approximately equal to the sum of the individual responses to 
ap MeATP and NA. There was no evidence however of synergism. This 
additive effect suggests that hydrolysis of PC is a level at which ATP 
and NA interact as co-transmitters in the rabbit saphenous artery.
17. In the in vivo dog preparation, the rank order of potencies for 
adenosine and adenosine analogues in decreasing hind limb perfusion 
pressure (HLPP) was 5 1-(N-ethylcarboxyamido) adenosine (NECA) > 
N6-2-phenylamino adenosine (PAA) > adenosine > N6-cyclopentyl 
adenosine (CPA) = (+)-N6-(2-phenylisopropyl) adenosine (r-PIA), which
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is consistent with recognised criteria for an A 2 ~adenosine receptor 
and in particular the subtype A 2 a .
18. The rank order of potencies of adenosine and adenosine analogues
in reducing heart rate (HR) in the in vivo dog preparation was NECA>
adenosine > CPA > r-PIA > PAA, which more closely resembles an A 2 ~type
adenosine receptor and in particular the A 2 k“type than the A-^  receptor
seen in rabbit and rodent heart.
19. The antagonist PD115199 was selective for the hind limb, while
PAA was a selective agonist at this s\+e. , suggesting that the
receptors in the hind limb differ from those in the heart.
20. PD116948, which has been shown to be relatively A^-selective in 
other preparations, was relatively non-selective in the in vivo dog- 
preparation. It produced only a small shift of the dose response curve 
to adenosine in the canine heart, equivalent to that produced by the 
A2~selective PD115199.
21. These results are consistent with the view that the adenosine
receptor in the dog hind limb is of the A 2 a~subtype and of the
A 2 b-subtype in the canine heart.
INTRODUCTION
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FOREWORD
When Langley in 1901 noted that adrenal extracts could mimic the 
response to sympathetic nerve stimulation in supra-renal bodies, it 
was probably the beginning of our understanding that nerves control 
the actions of muscles by the release of chemicals, now known as 
neurotransmitters.
Based primarily on subsequent evidence of the release from nerve 
endings of either an acetylcholine-like or an adrenaline-like (later 
found to be noradrenaline, Von Euler, 1946) substance, Dale (1933) 
coined the terms 1 cholinergic' and 1 adrenergic1 to describe action by 
these two kinds of chemical transmitters.
Vigorous research over the next 60 years showed that responses to 
noradrenaline and acetylcholine were initiated, not by interaction 
with a single receptor type in each case, but by multiple receptor 
subtypes, mediating a variety of responses.
Cholinergic receptors
The neurotransmitter acetylcholine has been shown to act on two main 
classes of receptors. These have been distinguished by their different 
sensitivities to the alkaloid substances muscarine and nicotine (Dale, 
1914) and have accordingly been named muscarinic and nicotinic. 
Muscarinic actions correspond to those of acetylcholine released at 
post-ganglionic parasympathetic nerve endings, with the exception of 
sweat secretion evoked by acetylcholine released from cholinergic 
fibres of the sympathetic nervous system (Rang & Dale, 1987) and the 
acetylcholine mediated release of endothelium derived relaxing factor
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(EDRF, Furchgott, 1981). Muscarinic receptors may also mediate 
pre-synaptic feedback mechanisms to modify release of transmitter 
substances from parasympathetic or sympathetic fibres (Rand et al., 
1982).
Nicotinic actions correspond to those of acetylcholine released at 
the ganglionic synapses of the sympathetic and parasympathetic 
systems, the motor end plate of skeletal muscle and the endings of the 
splanchnic nerves round the secretory cells of the supra-renal medulla 
(Rang & Dale, 1987).
Studies in pancreas, submandibular and lacrimal glands (Giraldo et 
al., 1987; Korc et al., 1987) further subdivided muscarinic receptors
into two subtypes - M^ and M 2 and subsequently, up to five different 
subtypes of muscarinic receptor have been proposed (Bonner, 1989). 
Similarly there are considerable pharmacological differences between 
the nicotinic receptors of striated muscle fibres and those of 
autonomic ganglia (Paton & Zaimis, 1951), while more recent work has 
suggested the presence of two more types of nicotinic receptor in the 
brain (Goldman et a l ., 1987), with perhaps a different structure for 
pre-and post-junctional nicotinic receptors.
Adrenoceptors
Based on the relative potencies of sympathomimetics on a variety of 
tissues, noradrenergic receptors were initially divided into two types 
- alpha (a) and beta ((3) (Ahlquist, 1948). This was later confirmed by 
the discovery of the selective (3 adrenoceptor antagonist 
dichloroisoproteronol (Powell & Slater, 1958), followed by pronethalol 
(Black & Stephenson, 1962) and propranolol (Black et a l ., 1964).
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f3-adrenoceptors are present in many arteries and non-vascular smooth 
muscle. Interaction with them has been shown in some cases to evoke a 
hyperpolarisation and relaxation (e.g. rat mesenteric artery, Nilsson 
et a l ., 1986). In addition, p-adrenoceptors may exist pre-junctionally 
and modify evoked transmitter release (see Dahlof, 1981).
Subdivision of a-adrenoceptors occurred on the discovery in rabbit 
heart (Starke, 1972) and cat nictitating membrane and spleen (Langer, 
1973) of pre-synaptic a-receptors which differed from those 
post-junctionally in effect as well as in location. Langer (1974) 
proposed that the post-junctional receptors should be termed a-^  and 
the pre-junctional c^. Antagonists have since been developed to 
distinguish between these two sub-types, the most selective of which 
is the a^-adrenoceptor antagonist prazosin (Cambridge & Davey, 1979).
It has since been confirmed that a-^-adrenoceptors exist 
post-junctionally and do not affect the evoked release of NA “(Parker 
et al., 1985; von Kugelgen & Starke, 1985), while pre-junctional
a^-adrenoceptors are widely distributed and are thought to regulate 
the release of noradrenaline through pre-junctional auto-inhibition 
(see Starke, 1987). (^-adrenoceptors also exist post-junctionally and 
can mediate contraction in a number of vessels (e.g. in hind limb of 
dog and cat, Gardiner & Peters, 1982; canine femoral bed, Eisner et 
al., 1984; pithed rat, Flavahan & McGrath, 1980).
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Current views on transmission were thus developed from the original 
work of Dale by detailed questioning and examining. The simplistic 
view that muscles were controlled throughout the body by only two 
chemical mechanisms, albeit by interaction with a number of receptor 
types, failed to explain a number of experimental findings. As far 
back as 1895, there had been recognition of 'atropine-resistant' 
responses, both excitatory (e.g. bladder, Langley & Anderson, 1895; 
Langley, 1898) and inhibitory (e.g. gastrointestinal tract, Langley & 
Anderson, 1895; Langley, 1898; Bayliss & Starling, 1899), to 
parasympathetic nerve stimulation. Indeed, even while developing the 
terms 'cholinergic' and 'adrenergic', Dale was encompassing a number 
of apparently anomalous results, for example sweat secretion, 
sympathetic vasodilation and paradoxical contracture of the lips in 
the dog (Rogowicz, 1885), where effects produced by sympathetic nerves 
were apparently transmitted by acetylcholine rather than by an 
adrenaline-type substance.
Despite the proposal by Henderson & Roepke (1934) that some as yet 
unknown motor transmitter was the major component in the production of 
the contractile response to nerve stimulation in dog bladder, 
anomalous observations were generally explained away within the 
existing cholinergic/adrenergic classification. Atropine resistance 
was frequently attributed to the release of acetylcholine out with the 
blockade produced by atropine - the 'barrier' theory (Dale & Gaddum, 
1930). Thus if acetylcholine was released outside the atropine 
'barrier', its effects were blocked, but if released inside, atropine 
was ineffective. This theory has largely been disproved by evidence 
from electron-microscopy that the gaps between autonomic varicosities
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where transmitter is released and the smooth muscle where transmitter 
acts are large and therefore no difficulty in atropine reaching its 
postsynaptic site of action was evident (see Gillespie, 1982).
Alternatively, anomalous effects were explained away by the so-called 
'peripheral mechanism1 (McSwiney & Wadge, 1928), in which the resting 
tone of the tissue was thought to determine the response to nerve 
stimulation. If tone was high, then either sympathetic or 
parasympathetic stimulation would produce relaxation. The 'peripheral 
mechanism1 theory has similarly been disproved, since most examples 
attributed to this mechanism have since been shown to result from 
mixtures of sympathetic and parasympathetic nerves (e.g. in stomach, 
Harrison & McSwiney, 1936 and rabbit colon, Gary & Gillespie, 1956).
The use of adrenergic neurone blocking drugs such as guanethidine, 
has uncovered some anatomically adrenergic nerves, insensitive to 
block by these drugs, in a manner analogous to those parasympathetic 
nerves which appeared insensitive to atropine (e.g. guinea-pig taenia 
coli, Burnstock et al., 1963a). Subsequently, in both the sympathetic 
and parasympathetic nervous system, examples were found which could 
not be explained by the classical view of transmission as either 
cholinergic or adrenergic and indeed many examples were soon found 
where neither the cholinergic, nor the adrenergic transmitter appeared 
to be involved. In the guinea-pig taenia coli for example, after 
blockade of both adrenergic and cholinergic responses, nerve 
stimulation still produced large transient hyperpolarisations (termed 
inhibitory junction potentials (i.j.p.s)), accompanied by relaxations 
(Burnstock et al., 1963; 1964; Bennett et al., 1966a; 1966b) These
results led to the idea of their being 'non-adrenergic,
non-cholinergic' (NANC) nerves and by the end of the 1960's, the 
existence of nerves releasing NANC transmitter substances were 
postulated in a variety of organs (see Burnstock, 1969; Campbell, 
1970), although the nature of the transmitters remained unclear.
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NANC NERVES
There is now functional evidence for NANC nerves in a wide variety of 
tissues. These have been shown to be largely postganglionic, 
parasympathetic nerves, releasing neither NA nor Ach and may be 
inhibitory, e.g. guinea-pig gall bladder (Davison et al., 1978), toad 
lung (Robinson et al., 1971), guinea-pig gastrointestinal tract (see 
Burnstock, 1979, Gillespie, 1982), guinea-pig trachea (Coburn & 
Tomita, 1973), rabbit portal vein (Hughes & Van, 1967), bovine 
retractor penis muscle (Byrne & Muir, 1985) and rat anococcygeus 
(Gillespie, 1972), or excitatory, e.g. dog urinary bladder (Creed & 
Tulloch, 1978; Muir & Smart, 1983), guinea-pig ileum (Ambache & 
Freeman, 1968; Bywater et al., 1981), cat colon (Hulten & Jodal,
1969).
Structural evidence for the existence of NANC nerves has been claimed 
from electron microscope studies. The predominance of opaque vesicles 
(LOVs) (Robinson et al., 1971) was observed in tissues, e.g. toad
lung, which exhibited NANC responses (Wood & Burnstock, 1967; 
Campbell, 1971). The distribution of LOVs remained unchanged when 
adrenergic nerves were abolished by 6-hydroxydopamine (6-OHDA). The 
morphological similarity of these LOV's to known peptidergic 
neurosecretory axons led other authors to term them p-type vescicles 
(Gibbins & Haller, 1979). Similar L O V s  were seen in other tissues 
which showed functional NANC innervation, e.g. avian gizzard 
(Burnstock, 1972) and bovine penis muscle (Eranko et al., 1976), while 
in rat anococcygeus muscle (Gibbins & Haller, 1979) a rather smaller, 
but morphologically similar opaque vesicle was observed, which was
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labelled small p-type (sp-type). These observations prompted the 
proposal that LOV's or sp-type vescicles contained the NANC 
transmitter in at least some tissues (Burnstock, 1982). While this 
proposal stimulated much interest in the nature of NANC nerves, such a 
clear cut ultrastructural distinction between NANC and cholinergic or 
adrenergic nerves has not always been possible. In a great number of 
autonomic nerve profiles, e.g. rabbit portal vein, guinea-pig trachea 
and rabbit urinary bladder, LOV's are no more common in NANC nerves 
than in cholinergic ones (Gibbins, 1982). The primary transmitter in 
NANC nerves may therefore be more often stored and released from small 
clear vescicles and the presence of a particular vesicle profile in
nerve endings cannot yet be related to the type of response (Gibbins, 
1982). This absence of a unique profile for NANC nerves has proved 
disappointing in establishing the existence of NANC transmitters in 
nerves. Attempts to identify the transmitter substances mediating NANC 
responses have nevertheless continued. Five criteria for the 
establishment of a substance as a neurotransmitter (Eccles, 1964) have 
been applied to candidates for this role.
The putative transmitter should:
1) be synthesized and stored in the nerve terminals
2) be released during nerve stimulation
3) produce postjunctional responses on exogenous addition which mimic 
the responses to nerve stimulation
4) be capable of inactivation by enzymes which are biologically
present and/or be removed by an uptake system in the nerve terminals
5) and responses to both exogenous transmitter and nerve stimulation
should be antagonised or potentiated by the same drugs.
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This last criterion has often proved to be the most difficult to 
meet, however those NANC substances which have most closely fulfilled 
the above criteria for transmitter substances can be largely grouped 
into peptides; released from 'peptidergic nerves' and purines; 
predominantly ATP, released from 'purinergic nerves' (for reviews see 
Burnstock, 1979; 1981; 1986; Hokfelt, 1980a) .
Peptides as transmitters
The first realisation that mammalian neurones produced and released 
peptides followed the characterisation of oxytocin and vasopressin as 
octapeptides (du Vigneud, 1955). These peptides were released into the 
blood supply from the posterior pituitary from neurones originating in 
the supraoptic and paraventricular nuclei of the hypothalamus.
On the basis of their presence in nerves, established by 
immunohistochemistry, radioimmunoassay and bioassay techniques, over 
30 peptides have since been proposed as possible NANC transmitters, in 
both CNS and periphery. These have included substance P, neuropeptide 
Y (NPY), vasoactive intestinal polypeptide (VIP), cholecystokinin 
(CCK), galanin (GAL) and bombesin. (see reviews by Hokfelt et a l ., 
1980a; Iversen, 1983b). Apart from their presence in nerves however, 
only a few of these come close to fulfilling the rest of the criteria 
necessary to establish them as transmitters.
Of these, the most promising are VIP and substance P. These peptides 
are particularly abundant in smooth muscle. For example, the 
longitudinal muscle of the guinea-pig taenia-coli is innervated by
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fibres which are immunoreactive to both VIP and substance P (Jessen et 
al ., 1980). The release of each of these peptides has been
demonstrated in vitro following nerve stimulation. For example, VIP 
was released into the venous outflow when NANC inhibitory nerves 
supplying cat stomach were stimulated (Fahrenkrug et a l ., 1978), while 
substance P was claimed to produce a contraction by its release from 
intrinsic nerves in the intestine (Franco et al., 1979). In addition, 
close-arterial infusion of VIP mimicked the nerve evoked relaxation of 
the cat stomach (Eklund et al., 1979) while substance P mimicked NANC 
nerve mediated contractions in the guinea-pig ileum (Bauer & Kuriyama, 
1982a). The last two of Eccles' criteria, 4 and 5, are however more 
difficult to apply to these two peptides. Substance P can be rapidly 
enzymatically degraded (Lee et a l ., 1981), but no such inactivation 
mechanism has been demonstrated for VIP, nor has any uptake mechanism 
been shown for any peptide and only little success has been achieved 
in the development of peptide antagonists. Some success in blocking 
the responses to VIP and NANC nerve stimulation have been claimed for 
active VIP anti-serum in the opossum oesophageal sphincter (Goyal et 
a l ., 1980), rabbit internal anal sphincter (Biancani et al., 1983) and 
cat trachea (Ito & Takeda, 1982), while (D-pro2 , D-Trp 7 '9 )-substance 
P has been proposed as a substance P antagonist (Leander et a l ., 1981) 
which suppressed contraction to NANC nerve stimulation in guinea-pig 
taenia-coli (see Bauer & Kuriyama, 1982a). These results are however 
by no means unequivocal.
Despite these problems, the possibility exists that VIP and/or 
substance P are NANC transmitters in some organs. Given that 
experimental protocols tend to look at short term effects of
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transmitters, while peptides can have actions lasting for an hour or 
more (e.g. neuropeptide Y (NPY), see Potter, 1985) the effects of the 
proposed transmitter may therefore have been missed. Other peptides 
may yet be shown to also act as NANC transmitters.
Purines as transmitters
Apart from the vital role of adenosine nucleotides in cellular 
metabolism (for review see Gillespie, 1934), the purine nucleotide 
adenosine 5'-triphosphate (ATP) was also known to stimulate both the 
peripheral and central nervous systems (see Gillespie, 1934; Buchthal 
& Kahlson 1944). Indeed, it was proposed almost 40 years ago that ATP 
might be a transmitter at rabbit sensory nerve endings (Holton & 
Holton, 1953). Later adenosine or ATP were shown to have potent 
extracellular actions on excitable membranes which may be involved in 
physiological regulation of for example, blood flow from the heart 
(Berne, 1963), skeletal muscle (Scott et al., 1965), kidney (Osswald 
et al., 1977) and brain (Rubio et al., 1975). Burnstock et al. (1970; 
1972) further proposed that a purine nucleotide, probably ATP was more 
than a modulator a n d .likely to be the NANC transmitter in many smooth 
muscle preparations, especially those receiving inhibitory NANC nerves 
of guinea-pig and toad intestine and excitatory nerves of guinea-pig 
bladder - the 'purinergic nerve 1 hypothesis.
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Application of the five criteria for a neurotransmitter (vide supra, 
Eccles, 1964), using histological, radiochemical and pharmacological 
techniques, provided substantial evidence to support the claim that 
ATP (or a related substance) could be an NANC transmitter. It was 
proposed (Robinson et al., 1971; Burnstock, 1982), although not
universally accepted (Gibbins, 1982), that ATP synthesized in the 
nerves was stored in the large opaque vesicles (LOVs) previously 
reported. After its release and its activation of postjunctional 
receptors, ATP was rapidly broken down by ATPase and 5 1-nucleotidase 
to adenosine. The adenosine so formed was taken up into the nerve 
terminal by a high affinity uptake system and reconverted into ATP. 
Exogenous addition of adenine nucleotides, particularly ATP, was shown 
to closely mimic NANC nerve responses in many smooth muscles. These 
could be either inhibitory, e.g. guinea-pig taenia-coli (Cocks & 
Burnstock, Burnstock, 1979) and gall bladder (Davison et al., 1978) or 
excitatory e.g. guinea-pig urinary bladder (Ambach & Zar, 1970; Muir & 
Smart, 1^83) and ileum (Bauer & Kuriyama, 1982a).
This mimicry extended not only to mechanical events, but to 
underlying electrical changes. For example, the electrical events 
associated with the relaxation produced by both ATP and NANC nerve 
stimulation in the guinea-pig taenia-coli (Axelsson & Holmberg, 1969) 
and ileum (Bauer & Kuriyama, 1982b) is an increase in K+ conductance. 
In those tissues where the electrical response to NANC nerve 
stimulation is small, e.g. rat anococcygeus (Gillespie, 1982) and 
bovine retractor penis muscle (Byrne & Muir, 1984), the response to 
ATP is likewise small.
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Rigid application of Eccles last criteria for a neurotransmitter, 
namely that drugs should antagonise or potentiate both the effects of 
the transmitter and nerve stimulation, has not always been possible. 
Furthermore, as with many other peripherally acting neurotransmitters, 
it now seems likely that there is more than one purinoceptor subtype.
Largely on the basis of the rank order of potencies of agonists, it 
has been proposed (Burnstock 1978) that purinoceptors be divided into 
two subtypes - P^ and P2 . At the P 2 _purinoceptor, the order of agonist 
potency was adenosine > adenosine 5 1-monophosphate (AMP) > adenosine 
5 1-diphosphate (ADP) > adenosine 5 1-triphosphate (ATP), while at the 
P2 -purinoceptor, the opposite order of potency, ATP > ADP > AMP > 
adenosine, prevailed.
The P^/Pg division was further supported by the evidence that
P^-purinoceptors were antagonised by methylxanthines such as 
theophylline (see Burnstock, 1978) and that their occupation led to 
changes (either increases or decreases) in intracellular cyclic 
adenosine monophosphate (cAMP) levels. At the P2 -purinoceptors by 
comparison, methylxanthines were not antagonists, nor were levels of
cAMP altered by occupation of this receptor type.
A  variety of actions may be considered for these subtypes of receptor 
and it has been proposed (Enero & Saidman, 1977; Su, 1978) that 
purinoceptors may exist both pre and post-junctionally. Thus ATP
released from pre-junctional nerve endings may act as a transmitter 
post-junctionally on P 2 _purinoceptors. In addition ATP will be broken 
down by 5 1-nucleotidase and by ATPase to adenosine, which may have 
further post-junctional actions on P^-purinoceptors. Adenosine may in
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addition act as a neuromodulator on P^-purinoceptors existing 
pre-junctionally to modify the release of transmitter substances via a 
regulatory feedback system.
Since Burnstock's initial (1978) division of purinoceptors into two 
subtypes, a further subdivision of both P^ and P 2 -purinoceptor types 
has been proposed.
The P 2 ~purinoceptor was divided into A 2 and A 2  receptors (van Calker 
et a l ., 1979) or alternatively, into R 2  and Ra subtypes (Londos et
al., 1980). The A 2 receptors appear to be analogous to the R 2  and A 2  
to Ra and the former nomenclature has been more widely accepted.
Since methylxanthines do not distinguish more than one type of 
P 2 -purinoceptor, further classification of these subtypes has been 
made biochemically by observing the rank order of potency of analogues 
in stimulating or inhibiting adenylate cyclase and hence cAMP levels. 
Pharmacologically, classification has been made by comparison of both 
the rank order of potency and affinity of adenosine and adenosine 
analogues as agonists. Thus A 2 ~receptors display a high affinity for 
agonists, inhibit adenylate cyclase (Dobson, 1983) and account for the 
negative chronotropic and inotropic effects of adenosine in rat, 
guinea-pig and rabbit atria (Collis, 1985; Haleen & Evans, 1985). The 
rank order of potency of agonists at A 2 ~receptors is 
N^-(2-phenylisopropyl)adenosine (PIA) > adenosine >
5 1-(N-ethylcarboxyamido)adenosine (NECA) (Londos et a l ., 1980), and 
this receptor exhibits a marked stereo-selectivity for the 
diastereoisomers of PIA, 1-PIA being 50-100 times more potent than
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d-PIA.
A 2 ~receptors on the other hand display a lower affinity for agonists 
than A-l receptors, generally stimulate adenylate cyclase (Kukovetz et 
al., 1978) and are present in bovine coronary arteries (Mustafa &
Askar, 1985) aortae (and presumably other blood vessels) and trachea 
of the guinea-pig (Collis, 1985). The reverse order of potencies 
exists for A 2 ~receptors, i. e. NECA > adenosine > PIA and little 
stereo-selectivity for isomers of PIA exists at this subtype.
While this subdivision of P^-purinoceptors into A 2 and A 2  has proved 
valid for a large number of tissues, anomalies have been observed. It 
has been proposed (Bruns et al., 1986; 1987) that these anomalies may 
reflect the existence of further subtypes of A 2  receptors - A 2 a and 
A 2 k- At an A2a receptor the order of potencies of adenosine and 
adenosine analogues is 5 1-(N-ethylcarboxyamido) adenosine (NECA) > 
N^-2-phenylamino adenosine (PAA) > N^-cyclohexyl adenosine (CHA) > 
(+)-N^-2- phenylisopropyl) adenosine (r-PIA), while at the A2^ 
receptor the order is NECA > CHA > r-PIA > PAA. The selectivity of 
antagonists for the A 2 a-subtype is represented by PD115199 > PD116948, 
while for A-2b' PD115199 = PD116948, with both antagonists having a low 
affinity for this receptor subtype.
In the open chest dog (Kusachi et al., 1983), in the conscious dog 
and in isolated canine atria (Belloni et al., 1989), the order of 
agonist potency differed from that accepted for the A-preceptor 
subtype in rodent and rabbit heart and in some ways more closely 
resembled the A 2  subtype of receptor. It was proposed that a novel 
receptor type existed in the canine heart and this may reflect the 
presence of one of the subtypes A 2 a or A 2 b.
pg. 33
Subtypes of P2 -purinoceptor have likewise been proposed and analysis 
of the rank order of agonist potency, combined with functional 
differences, allowed two subtypes, P2x and P2y, to be distinguished 
(Burnstock & Kennedy, 1985).
The p2 x receptor subtype mediates the contractile effects of purines 
in smooth muscle (e.g. urinary bladder of guinea-pig and rat) and the 
rank order of potency of ATP and its analogues as agonists is 
a(3-methylene ATP (a(3 MeATP) = p^-methylene ATP (pY MeATP) > ATP = 
2-methylthioATP. P2y receptors mediate the inhibitory responses evoked 
by purines (e.g. guinea-pig taenia coli) and the rank order of potency 
of agonists is 2-methylthio ATP »  ATP > a(3 MeATP = (3Y MeATP
(Burnstock & Kennedy, 1985).
Recently developed structural analogues of ATP which antagonise 
responses mediated by P2 X receptors have made important contributions 
to the problems of blockade of ATP-mediated responses.
Arylazido aminopropionyl-ATP (ANAPP3 ), is thought to form covalent
bonds with the excitatory P2 -purinoceptor (i.e. ?2 x) on irradiation
with visible light and has been used as an irreversible
P 2 X~purinoceptor antagonist in a number of tissues, e.g. guinea-pig 
vas deferens (Hogaboom et al., 1980; Fedan et al., 1982), rabbit
anococcygeus (Sneddon et al., 1982). It does not antagonise inhibitory 
responses mediated by P2 y-purinoceptors, e. g. guinea-pig taenia coli 
(Westfall et a l ., 1982).
Contractions to ATP are also inhibited by repeated administration of 
the slowly degradable analogue of ATP, a(3 methyleneATP (a0 MeATP,
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Burnstock & Kennedy 1985). ap MeATP is a potent agonist producing a 
transient depolarisation and contraction. Repeated administration 
causes a prolonged desensitisation of the P2 X~purinoceptor, even after 
the initial depolarisation and contraction have disappeared (Meldrum & 
Burnstock, 1983; Sneddon & Burnstock, 1984b; von Kiigelgen & Starke, 
1985, Kennedy et a l ., 1986).
A  compound more recently proposed as a suitable antagonist of 
P2 X~purinoceptors -'-s suramin (see methods section for chemical name). 
In mouse vas-deferens (Dunn and Blakeley, 1988), pithed rat 
(Schlicker et al., 1989) and rabbit ear artery (Leff et a l ., 1990),
suramin antagonised purine responses evoked by ap MeATP or ATP, 
without any significant effect on cholinergic or noradrenergic 
responses.
Despite the widespread use of ap MeATP in the study of 
P 2 X*-purinoceptors, doubts have been cast on the selectivity of this 
agent.
In the chicken rectum, the initial large depolarisation produced by 
ap MeATP did not entirely disappear and this residual depolarisation 
was accompanied by changes in membrane conductance (Komori et al., 
1988). Perhaps as a result of the residual depolarisation caused by 
this drug, ap MeATP attenuated the responses evoked by some 
non-purinergic agonists e.g. KC1 and bovine neurotensin (Komori et 
al., 1988). ap MeATP also allegedly attenuated depolarisations to NA
in the rat basilar artery (Byrne & Large, 1986).
Further, in the chicken rectum, smooth muscle cells regained normal 
membrane resistance and sensitivity to exogenous addition of ATP on 
washout of a desensitising block produced by ap MeATP, more rapidly
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than to the evoked e.j.p.s (Komori et al., 1988). This was proposed to
be the result of an unknown extra effect of ap MeATP in addition to
its effect on P2 _purinoceptors.
Kotecha & Neild (1987) similarly suggested that ap MeATP had
properties other than desensitisation of purinoceptors and proposed 
that this compound was a blocker of cation channels in rat tail
artery.
While some progress has been made in inhibiting P2 X responses, little 
progress has been made in finding selective antagonists for P2 y 
receptors and this to some extent delayed the acceptance of the 
'purinergic nerve 1 hypothesis.
Apamin, a bee neurotoxin inhibits the relaxation and inhibitory 
junction potentials in guinea-pig taenia coli (P2 y K  in the absence of 
any inhibition of the excitatory (?2 y) effects of purines in 
guinea-pig urinary bladder or rat uterus (Shuba & Vladimirova, 1980). 
Apamin however acts by blocking certain K+ channels rather than by 
interaction with purinergic receptors. Reactive blue 2 has also been 
used to distinguish between P2y and P2x receptors but this also has a 
non-specific effect, perhaps acting by interference with biochemical 
processes regulating the availability of potassium and calcium 
channels. (Kerr & Krantis, 1979; Manzini et al., 1986). The actions 
of these drugs have however allowed some distinction between subtypes 
of P 2 -purinoceptor.
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Although the hypothesis of purinergic transmission was attractive, it 
was not universally accepted. The lack of selective antagonists for 
all receptor subtypes and the criticisms of those existing 
purinoceptor inhibitors, left this hypothesis not fully proven. The 
ubiquitousness of ATP and its importance in cell metabolism similarly 
made it difficult to prove ATP's role as a transmitter. Several 
authors raised specific doubts about ATP in this role, based on the 
low potency of ATP in some preparations supplied by NANC nerves (e.g. 
in producing contraction of rat bladder, Brown et al., 1979). This has 
since been explained by the proposal that rapid breakdown of ATP to 
AMP and adenosine accounts for the low potency (Ambache et a l ., 1977a: 
1977b). Other authors found that although tachyphylaxis to ATP in, for 
example, the rabbit ileum (Burnstock et al., 1970) produced depression 
of the response to purinergic nerve stimulation, this was not seen in 
the guinea-pig urinary bladder (Ambache & Zar, 1970). It has since 
been shown however (Burnstock et al., 1978) that in the presence of 
indomethacin to inhibit ATP evoked prostaglandin synthesis, the 
response to nerve stimulation is virtually abolished following 
desensitisation to ATP.
Accordingly, many of those objections raised to the 'purinergic 
nerve' hypothesis have been refuted or explained away and there is now 
good evidence for ATP as a neurotransmitter in some, but not all NANC 
nerves. Nevertheless, some gaps in the literature still exist and must 
be filled before ATP's role in transmission is fully accepted.
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Other putative NANC transmitters
While purines and peptides are currently the main contenders for the 
role of NANC transmitters, other classes of compound may also function 
in this role. 5-hydroxytryptamine (5-HT) or a closely related 
indolamine, present in enteric neurones, may satisfy the criteria 
(Eccles, 1964) for a transmitter (e.g. in guinea-pig colon and ileum, 
Furness & Costa, 1979; guinea-pig small bowel, Wood & Mayer, 1979). 
Similarly, y-aminobutyric acid (GABA), which is a major
neurotransmitter in the CNS (Iversen, 1972), has been proposed as an 
NANC transmitter in the gastrointestinal tract (e. g. in guinea-pig 
taenia coli, Jessen et al., 1979X, while dopamine has been proposed 
for this role in some blood vessels (Bell, 1982). While the evidence 
for these other substances as NANC transmitters is as yet less 
convincing, their importance may become apparent as more
substantiating facts accrue.
It is clear that control of muscle function by nerves can no longer
be seen to be the domain of Ach and NA alone.
Our understanding of the existence of NANC transmitters was arguably 
one of the most significant advances in the study of autonomic control 
since the inception of the concept of chemical transmission. It added 
to the complexity of our understanding of nervous control and provided
pg. 38
the impetus for a renewal of interest into the nature and function of 
transmitters. The next major advance was to be concerned with the 
number of neuronal transmitters involved in the effector response.
The above evidence for NANC transmitters was still encompassed within 
the concept that each nerve synthesizes and releases only one 
transmitter (widely known as Dale’s Principle), however reexamination 
of Dale's original views (Dale, 1935) led to the view that while any 
one class of nerve cell operated at each of its synapses by the same 
chemical transmission mechanism (Eccles, 1986), this does not exclude 
the possibility that more than one transmitter could comprise the 
"chemical transmission mechanism" in each case. (Eccles, 1986). The 
feasibility of this idea lies in the interpretation of the methods by 
which transmitters evolve.
Two opposing views have been put forward for the mechanism by which 
new neurotransmitter systems evolve. One theory proposed that neurones 
have a common origin and that they differentiate into various types in 
the course of evolution, due to functional specialisation (see 
Burnstock, 1969). An alternative view is that there were multiple 
origins of nerve cells, resulting in a wide diversity of 
neurotransmitters early in evolution. The eventual reduction in the 
number of transmitters was the result of selection (Sakharov, 1974). 
Either way, it seemed conceivable that a gradual evolutionary 
transmission from one neurotransmitter to another occurred and that 
this might lead to nerves with more than one transmitter, (see 
Burnstock, 1981). It was perhaps then not surprising that recent 
years have seen increasing evidence that, in addition to being present 
in separate neurones, many of these putative transmitter substances
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are stored together with the classical transmitters, either in the 
same, or in separate vescicles, are co-released following stimulation 
of both parasympathetic and sympathetic nerves and may perhaps act 
together postjunctionally - the idea of co-transmission.
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CO-TRANSMISSION
Early evidence to support this idea came from the observation that an
adrenaline-like substance was detected in the perfusate of the cat
superior cervical ganglion following pre-ganglionic stimulation 
(Bulbring, 1944). Subsequently, using histological techniques, Koelle 
(1955) showed that acetylcholinesterase (AchE) - the enzyme involved 
in the hydrolysis of acetylcholine (Ach) was present in several 
adrenergic nerves of cats, rabbits and rhesus monkeys. Koelle 
concluded from these observations, that the terms cholinergic and 
adrenergic neurones (Dale, 1933), might be used to refer to the
predominant, rather than the exclusive type of transmitter of the
nerve fibres and that fibres might liberate mixtures of chemical 
transmitter (Koelle, 1955).
Using similar techniques, Abrahams et al., (1957) examined the
distribution of acetylcholinesterases in the dog hypothalamus. They 
found that true cholinesterase (AchE, indicating cholinergic neurones) 
was found in the areas of the supraoptic, the suprachiasmatic and the 
paraventricular nuclei - all areas assumed to secrete hormones 
(oxytocin and vasopressin). They proposed that this could reflect the 
ability of the initial release of the neurone1s transmitter to 
stimulate production of the nerve1s own endocrine product.
Histochemistry was again used to examine the distribution of AchE in 
the cat superior cervical ganglion (Koelle & Koelle, 1959). At this 
site, functional AchE existed only presynaptically, in contrast to the
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neuromuscular junction, where most of the enzyme was located 
post-synaptically. From this it was inferred that AchE served 
different primary functions at the two sites. It was proposed (Koelle, 
1961), that a dual role existed for Ach, in that released Ach acted 
initially on pre-synaptic sites to activate the ganglion and cause a 
secondary release of Ach which acted on post-synaptic sites.
This work suggested that release of even a single transmitter 
involved a more complex series of events than previously seen. The 
'marrying' of the idea of a two phased release of a single 
transmitter, with the possibility of the release of more than one 
substance was proposed (Burn & Rand, 1965) to explain the ability of 
Ach and nicotine to produce effects like those of sympathetic 
stimulation in many organs. Using post-ganglionic sympathetic nerves, 
they proposed that the initial response to nerve stimulation was the 
release of Ach from axonal terminals, which caused an increased influx 
of calcium ions into the nerve terminal, triggering the release of the 
actual neuroeffector transmitter, noradrenaline, from the same 
terminals. This was called the 'cholinergic link 1 hypothesis (for 
review see Burn & Rand, 1965) and implied the co-existence and release 
of both Ach and noradrenaline (NA). While these proposed systems 
assumed a more complicated picture of transmission than had previously 
been recognised, neither Koelle, nor Burn & Rand however proposed a 
postjunctional effect of more than one substance.
Evidence that two transmitter substances may act postjunctionally, 
came from an electrophysiological study of single isolated sympathetic 
neurones grown on heart cells (myocytes) previously dissociated from 
new-born rats. It was shown that some neurones released NA, some Ach
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and some released both NA and Ach (Furshpan et al., 1976). Those
neurones which released NA evoked myocyte stimulation; those which 
released Ach produced inhibition; while those which produced both NA 
and Ach, first inhibited and then stimulated the myocytes.
This then implied that not only was co-existence and co-release of 
the 'classical' transmitters (i.e. Ach and NA) possible, but that 
these could in fact operate as co-transmitters.
Co-transmission of the 'classical' transmitters with putative NANC 
transmitter substances may also exist (see reviews by Hokfelt et a l ., 
1980; Iversen, 1983).
Much of the evidence for co-transmission came from observation of 
tissues where a-adrenoceptors antagonists were only partly effective 
in blocking the responses to nerve stimulation. For example, in the 
rat vas deferens (vide infra, McGrath, 1978), field stimulation evoked 
an initial rapid contraction, followed by a second, slower and more 
prolonged contraction. Only the second slow contraction was abolished 
by a-adrenoceptor antagonists, or mimicked by NA. Furthermore, in the 
rabbit ear and saphenous artery (Holman & Surprenant, 1980), 
a-adrenoceptor antagonists depressed, but did not abolish contractions 
produced by nerve stimulation.
Controversy surrounds the precise definition of co-transmission. It 
has been defined as simply the pre-junctional release of more than one 
transmitter (O'Donohue et al., 1985), leading in theory, to four
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potential mechanisms by which co-transmitters could interact. First, 
each transmitter could bind to the same post-junctional receptor, or 
secondly, to different receptors on different target cells. Thirdly, 
one transmitter could modulate the action of the other in the synaptic 
cleft, at the same postjunctional receptor (perhaps by changing the 
sensitivity of receptors for the other transmitter, see Koketsu, 1984) 
or at the level of second messengers or ionic channels. Lastly, each 
transmitter could bind to different receptors on the same cell.
Other authors (see Campbell, 1987) suggest that co-transmission must 
be defined in terms of the target cell and that co-transmission exists 
only where two or more transmitters act on the same target cell so 
that the net result of transmission incorporates interactive effects 
of the transmitters. For the purposes of this thesis, I have chosen to 
accept the latter definition.
Not surprisingly perhaps, those substances proposed as transmitters 
in non-adrenergic, non-cholinergic nerves, were in many cases also the 
most likely candidates for co-transmitters and while co-transmission 
with more than one NANC transmitter has been postulated in some cases 
(e.g., dopamine with cholecystokinin (CCK) in the central nervous 
system of rat and man (Hokfelt et al., 1980)), the most important 
examples of co-transmission occur where the classical transmitters 
-Ach or NA - are combined with one or more NANC putative transmitter 
substances - particularly peptides or purines.
There is now evidence for co-transmission of purines or peptides 
together with Ach or NA (see Cuello, 1982; Osborne, 1983; Chan-Palay &
Palay, 1984) in a large number of tissues. The relative importance of 
these to the concept of co-transmission will be discussed in the 
following sections.
Co-transmission of 'classical' transmitters with peptides
The possibility that peptides may act as co-transmitters is not 
perhaps surprising considering the early proposal (Abrahams et al., 
1957) that Ach might evoke the release of peptides from dog 
hypothalamus. Evidence to support the idea of the co-existence of a 
classical transmitter with a peptide came from work in endocrine cells 
in gastrointestinal tract (Pearce, 1969), where cells were shown to 
contain both a biogenic amine, such as 5-HT or histamine and a peptide 
such as substance P, somatostatin or neurotensin. These cells were 
part of the APUD (amine content or precursor uptake and 
decarboxylation) system, the cells of which are 'neuroendocrine 
-programmed 1 cells originating from the same ectoblast'. Since 
neurones have the same embryonic origin as endocrine cells, it was 
proposed that neurones may also contain both an amine and a peptide 
(Pearce, 1969). Indeed a population of guinea-pig sympathetic ganglion 
cells was subsequently found to be somatostatin-immunoreactive 
(Hokfelt et al., 1977).
Since then, extensive evidence for co-existence of peptides with 
classical transmitters has come from immunohistochemical techniques, 
where positive staining for a given peptide has been demonstrated in
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autonomic neurones. Iversen (1984) lists 32 peptides that are 
constituents of neurones and nerve terminals in the central nervous 
system (CNS) alone.
The importance in transmission of each of these examples is however 
unlikely to be uniform and while co-existence and indeed co-release of 
putative transmitters is essential for, it is not sufficient evidence 
per se, of co-transmission. Not surprisingly then, not all of these 
substances are themselves transmitters (vide supra, Eccles, 1964) and 
a variety of functions for these peptides has been suggested, with 
corresponding names (Dismukes, 1979), such as neurohormones, 
neuromodulators or neuroregulators. Nevertheless, a number of peptides 
may fulfil the required criteria for transmission and may be released 
along with other transmitters during nerve stimulation to act as 
co-transmitters (for review see Burnstock, 1981).
Evidence that a neurone may contain more than one neurotransmitter 
has led to investigations concerning the manner in which these 
putative transmitter may be stored. It has been proposed (Cook & 
Burnstock, 1976) that in many tissues, the NANC transmitter appears to 
be stored in discreet vesicles. A separate storage system for each of 
the putative transmitters would appear to allow differential release 
of the co-transmitters at, for example, different impulse frequencies.
Such a functional role for co-transmission of a peptide with a 
'classical' transmitter and indeed one of the few in vivo examples of 
co-transmission, was demonstrated with vasoactive intestinal 
polypeptide (VIP) and acetylcholine (Ach) in the cat submandibular 
salivary gland (Lundberg & Hokfelt, 1983) . In this case, stimulation 
of nerves at low frequencies (2Hz) released Ach (as evidenced by
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atropine blockade), which produced both salivation and vasodilation. 
At higher frequencies however (>10Hz), the vasodilation became 
atropine resistant; an effect attributed to the co-release of VIP 
which potentiated the Ach-induced salivation by a direct vasodilation. 
Here co-transmission allowed a response to take place which could be 
varied physiologically depending on circumstances and which 
constituted a mechanism by which a demanding situation could be dealt 
with locally.
Another peptide implicated in co-transmission has been neuropeptide Y 
(NPY). This is a potent vasoconstrictor in cat pial arteries 
(Edvinsson et al., 1984), cat salivary glands (Lundberg & Tatemoto,
1982), guinea-pig uterine arteries (Morris et al., 1985) and rat tail 
arteries (Neild, 1987). At low concentrations, NPY potentiates the 
contractile responses of each artery to noradrenaline (NA) and to 
perivascular nerve stimulation. These observations have led to the 
suggestion that NPY may participate in the physiological control of 
artery diameter (Nield, 1987) and hence vascular tone.
The finding of peptides, previously associated with NANC transmission 
in the gut, e.g. VIP (Larsson, 1976), in many areas of the brain, 
resulted in the view that the CNS, the peripheral autonomic nervous 
system and the endocrine system have a number of peptides or families 
of peptides in common (Pearce, 1979). This suggested that 
co-transmission may also exist in the CNS. A particularly interesting 
example of this was seen in the occurrence of a CCK-like peptide in a 
sub-population of dopamine neurones in the meso-limbic system in man.
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(Hokfelt et al., 1980a). The meso-limbic dopamine systems have been
associated with higher mental functions and disturbances in them may 
represent one component in the pathogenesis of schizophrenia (Pearce 
et a l . , 1977), indeed it has been proposed that an imbalance between 
peptide and amine could be an aetiologic factor for schizophrenia 
(Hokfelt et al., 1980c)
Clearly there is evidence for co-transmission of peptides with 
'classical' transmitters in both the periphery and the CNS. Much of 
the evidence rests however, at least in the mean time, on the 
localization of the peptides in neurones and comparatively little is 
known about their physiological role. This is partly due to a lack of 
drugs which can influence peptide-induced events at synapses. Future 
developments may clarify the importance of co-transmission involving 
peptides.
Co-transmission of 'classical' transmitters with purines
Evidence that ATP, in addition to being an energy source, could act 
in its own right, together with other substances, came from the 
observation that the cat adrenal gland could accumulate and 
phosphorylate [3 H]-adenosine and that stimulation of the gland with 
carbachol resulted in the appearance of [ H]-ATP in the perfusate
(Stevens et al., 1972). It was proposed (Van Dyke et al., 1977) that
this ATP acted within the medulla as a 'co-agonist' along with 
simultaneously released catecholamines. The ATP could act either
directly on receptors or indirectly by being transformed into cyclic
nucleotides.
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Similar results were obtained in the guinea-pig taenia coli, where 
stimulation of the periarterial adrenergic nerves released [2 H] from 
tissues pre-incubated with [3 H]-adenosine (Su et al., 1971). This 
effect was abolished by the adrenergic neurone blocking agent 
guanethidine, suggesting that the purine was released from adrenergic 
rather than purinergic nerves.
In the course of the aforementioned experiments on isolated myocytes, 
Furshpan et a l . (1976) observed a neuronally evoked hyperpolarisation 
which was atropine resistant. Later work showed this to be antagonised 
by adenosine receptor blockers (Furshpan et al., 1986) and it was 
proposed that the hyperpolarisation was mediated by a purine. The 
authors suggested that in addition to co-releasing NA and Ach, many 
neurones may also release a purine.
Further evidence that ATP may act together with Ach comes from the 
observation that both these substances are found together in synaptic 
vesicles of cholinergic nerves supplying the electric organ of Torpedo 
(Dowdall et al., 1974). ATP is also released together with Ach from 
the phrenic nerves in the rat hemi-diaphragm (Silinsky & Hubbard, 
1973; Silinsky, 1975). It is however as a putative co-transmitter with 
NA that ATP has been most often studied and a functional role for ATP 
as a co-transmitter shown.
As previously mentioned, work on the rat vas-deferens gave early, 
relatively clear evidence for ATP and NA as co-transmitters. In this 
tissue the contractile response to sympathetic nerve stimulation is 
biphasic (McGrath, 1978). The early rapid twitch contraction was
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mimicked by ATP and unaffected by a-adrenoceptor antagonists or by NA 
depletion with reserpine. The second, slower phase was mimicked by NA 
and blocked by a-adrenoceptor antagonists. Similarly in the rat tail 
artery (Cheung, 1982), field stimulation produced e.j.p.s, which were 
resistant to both phentolamine and yohimbine -respectively a^ and 
a 2 -adrenoceptor antagonists - and a slow depolarisation which was 
blocked by phentolamine.
Many studies have since further examined the role of these two 
putative transmitters in the light of the development of relatively 
selective antagonists for ATP and have concluded that NA and ATP (or a 
closely related substance) are co-transmitters in a number of tissues 
including many vascular tissues, e.g. rat tail artery (Sneddon & 
Burnstock, 1984a), rabbit ear artery (Suzuki & Kou, 1983; Allcorn et 
al., 1985), aorta & portal vein (Su, 1978) and dog basilar artery 
(Muramatsu et al., 1981).
The inclusion of the concept of co-transmission complicates the 
factors which regulate the nervous control of muscle. Not only must we 
concerned with the nature of the putative transmitters released, but 
how as co-transmitters they may act and/or interact, in what ratio and 
under what conditions of stimulation they are released. While 
multiple release may permit finer control of muscle by nerves, or may 
perhaps constitute ’failsafe1 mechanisms for the relevant organ, 
predicting the result of the interaction two or more co-transmitters 
becomes difficult.
In this thesis, the main points of interest are the post-junctional 
actions, as co-transmitters, of NA (acting via a^-adrenoceptors) and 
ATP (acting via P 2 X-purinoceptors) in producing contractions in the 
smooth muscle of blood vessels. As mentioned, both NA and ATP may 
however also act as co-modulators by stimulating respectively 
<*2 -adrenoceptors and P 2 ~purinoceptors situated pre-junctionally. A 
schematic representation is shown in Fig. 1 of some possible 
interactions between NA and ATP.
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Fig. l. a  schematic representation of the current view of 
sympathetic neurotransmission by NA and ATP, demonstrating the 
position of pre-and postsynaptic adrenergic and purinergic 
receptors.
While many studies have accepted the phenomenon of co-transmission as 
being a logical and substantiated explanation for those situations 
where blockade of cholinergic and/or adrenergic transmission unmasked 
a residual NANC component of the response, an alternative explanation 
has been proposed in some cases.
For example, a further subtype of adrenoceptor has recently been 
proposed to explain the inability of a-adrenoceptor antagonists to 
inhibit the response to field stimulation of intramural nerves in some 
tissues. Hirst & Neild (1980; 1981), found that responses to
iontophoretically applied noradrenaline in guinea-pig arteriolar 
tissue varied according to the site of application. The contraction 
evoked by NA added extra-junctionally (i.e. added to regions distant 
from the sympathetic nerves) was a-adrenoceptor mediated (as evidenced 
by susceptibility to a-adrenoceptor antagonists) and was unaccompanied 
by changes in membrane potential. The response to junctionally (i.e. 
close to the sympathetic nerves) added NA was on the other hand, 
resistant to a-adrenoceptor blockade and was accompanied by a 
depolarisation. It was proposed that this latter response was the 
result of the interaction of NA with a novel adrenoceptor - a 'gamma' 
(F) receptor. A F-adrenoceptor has since been proposed in other 
tissues, e.g. the guinea-pig mesenteric artery and vein (Hirst & 
Jobling, 1989), as a low affinity noradrenaline receptor, which may 
exist in more than one sub-type. In the basilar artery, doses of NA as 
high as 1CT3M failed to produce a contraction, however these high
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doses of NA did produce changes in membrane potential which were 
resistant to a-adrenoceptor blockade (Hirst et al.# 1982). It was
argued that this reflects the presence of F-adrenoceptors.
The ' F 1 theory has however not received widespread acceptance. 
Criticisms of this theory have been based on the grounds that the 
detailed crucial localization experiments have been carried out on 
only one type of blood vessel, in one species, namely the submucosal
arterioles of the guinea-pig. Changes in tone of this tissue were not
measured during these experiments, nor was the nature of its
innervation or transmitter(s) known. In those experiments in the rat 
basilar artery, it has been suggested that the presence of a 
predominance of (3-adrenoceptors was overlooked and that the 
identification of receptors by exclusion in a tissue which does not 
contract to the physiological agonist seems precarious (Bevan, 1984). 
Accordingly, while the possibility that F-adrenoceptors exist has not 
been excluded, the physiological relevance of these receptors, should 
they exist, is as yet unclear.
The next stage in the understanding of the relevance of 
co-transmission has been to evaluate the post-junctional coupling 
mechanisms by which ATP and NA, the co-transmitters in vascular smooth 
muscle act and/or interact to produce their physiological response.
MECHANISM OF ACTION OF NA AND ATP
The possibility exists that these putative transmitters may each 
utilise different receptor-effector linkage mechanisms 
post-junctionally to produce contraction.
Interaction of a neurotransmitter or an appropriate ligand, with a 
cell surface receptor triggers a number of receptor-effector linkage 
mechanisms, which can be, grouped into three types.
1) Where the receptor is part of the same macromolecule as an ion 
channel and directly regulates membrane permeability to ions. This is 
the fastest type of receptor mediated response and a number of 
examples have been shown where this occurs, including the L-glutamate 
receptor in the CNS (Nistri, 1983). The best known example is however 
the nicotinic acetylcholine receptor (see Bowman, 1980; Blusztajn,
1983). Here Ach acts on the linked receptor/ ion channel complex to 
transiently increase its permeability to cations, resulting mainly in 
an increase in sodium and potassium permeability and to a small 
extent, calcium. This results in a net inward current which 
depolarises the cell (Skok, 1980) and increases the probability that 
it will reach the voltage potential required to open voltage-dependent 
sodium channels and thereby generate an action potential.
2) Where the receptor and ion channel are linked via a G-protein.
A G-protein is a peripheral membrane protein consisting of a, (3 and V 
subunits. There are several subtypes of G-proteins, mediating a 
variety of effects and distinguishable by differences in the a-subunit 
of the protein (Bourne, 1986). In general terms however, G-proteins 
respond when a receptor protein is stimulated by releasing guanosine 
diphosphate (GDP) and binding guanosine triphosphate (GTP). In its 
GTP-bound conformation, the G-protein can regulate the function of 
many effectors. Hydrolysis of bound GTP to GDP terminates the 
regulatory effect of a G-protein (Bourne, 1986).
Recent studies have reported the possibility that G-proteins may 
exert direct control over the function of ion channels. It has been 
shown that muscarinic agonists activated an inward rectifying K+ 
channel, which was not prevented by cyclic AMP (cAMP) analogues or by 
isoprenaline (Pfaffinger et al., 1985; Breitwieser & Szabo, 1985). 
Further evidence that no second messenger appeared w w  involved in 
activation of this channel came from cell-free patch preparations 
(Yatani et al., 1987). This channel activation required the presence 
of a GTP-containing solution and was blocked by pertussis toxin; an 
agent which catalyses the ADP-ribosylation of some G-proteins 
(Northrup, 1985). While these experiments do not prove direct 
interaction between G-protein and channel (see Gilman, 1987), this 
mechanism nevertheless remains a possible means by which muscarinic 
agonists act. Similarly, two subtypes of G-protein, GQ and G^ have 
been suggested as possible mediators of neurotransmitter induced 
inhibition of voltage-dependent Ca^+-channels (Holz et al^, 1986).
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3) Where the receptor and ion channel are linked via a G-protein and 
enzyme system.
There are several mechanisms which can be encompassed within this 
heading, including activation and inhibition of adenylate cyclase (for 
review see Gilman, 1987). Within the context of contraction in 
vascular smooth muscle however, stimulation of phosphatidylinositol
4,5-bisphosphate (PIP2 ) hydrolysis and more recently, stimulation of 
phosphatidylcholine (PC) hydrolysis are particularly relevant. In each 
case of this type of receptor-effector linkage system however, 
G-protein activation leads to alterations in levels of a second 
messenger within the cell, which subsequently evokes cellular 
responses. These second messengers may result in changes in the state 
of phosphorylation of various intracellular proteins whose catalytic 
activity is thereby regulated (Schulman, 1982), or in changes in 
levels of calcium (see Putney 1984) .
Stimulation of phosphatidylinositol bisphosphate (PIP?) hydrolysis.
Hydrolysis of PIP2 represents a pathway which, by the production of 
two different second messenger systems, can evoke both types of 
cellular response mentioned above; phosphorylation of proteins and 
changes in Ca^+ levels.
The binding of a transmitter to a cell surface receptor leads, once 
again via a G-protein, to the activation of an enzyme, this time a 
phosphodiesterase, phospholipase C (PLC) and then to the production of 
the second messengers, inositol 1 ,4 ,5 -trisphosphate (IP3 ) anc^
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diacylglycerol (DAG). PIP2  hydrolysis is a mechanism which has been 
shown to occur in response to a wide variety of stimuli (for review 
see Berridge, 1987) and is relevant to this thesis, since it has been 
shown to mediate the contraction to agonists in smooth muscle (see 
later).
In animal cells there are three myoinositol containing phosphatides; 
phosphatidylinositol [l-(3-sn-phosphatidyl)] -d-myoinositol (PI), 
phosphatidylinositol -4- phosphate (PIP) and phosphatidylinositol 
-4,5-bisphosphate (PIP2 ) (see Michell, 1975; Downes & Michell, 1982; 
Berridge, 1984). These phosphatidylinositols (Ptd Ins) are highly 
metabolically active but comprise less than 1 0 % of the total 
phospholipid content in animal cells (PI comprising the largest part 
of this .(>90%)).
A chance observation by Hokin & Hokin (1953) that incorporation of 
[32pj-phosphate into lipids in pigeon pancreas slices was greatly 
stimulated by acetylcholine (Ach), gave the first evidence that Ptd 
Ins had a role in cell function. This incorporation of [3 2 P] was later 
associated with a specific increase in the turnover of Ptd Ins in 
response to a wide variety of external signals (see Hokin & Hokin, 
1964; Michell, 1975; Putney, 1981; Berridge, 1984).
Degradation of the predominant inositol containing lipid - PI -was 
initially believed to be the primary consequence of receptor occupancy 
and accordingly the term phosphatidylinositol or 'PI' response was 
used to describe this phenomenon. Later however the G-protein mediated 
hydrolysis of PIP2  by phospholipase C (PLC), with the subsequent
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formation of diacylglycerol (DAG) and inositol (1,4,5) triphosphate 
(IP3 ) (Michell et a l ., 1981; Berridge, 1983) was shown to be the 
initial response. That the inositol lipid cycle might in some way 
serve as a biochemical coupling mechanism linked to receptor 
activation and cellular Ca2+ mobilisation had already been proposed 
(Michell, 1975) and the means by which receptor occupation was linked
*2 4*
to changes in Ca was presumed to be via a second messenger. It was 
Berridge (1983) who suggested that inositol (1,4,5) triphosphate 
(1(1^4,5)P^) was a likely candidate for a second messenger, it being 
rapidly formed in response to receptor occupation and able to release 
Ca2+ from the endoplasmic reticulum (Berridge, 1983; Berridge & 
Irvine, 1984; Putney, 1986).
Receptor mediated changes in intracellular Ca2+ have now been shown 
to occur as a result of both intracellular release by IP3 , probably 
from a Ca2+ pool in the endoplasmic reticulum (Burgess et al., 1983;
Streb et al., 1984) and sequential or concomitant slow entry of 
extracellular Ca2+ (Putney, 1979; Putney et al., 1981).
Since then the metabolic pathway for the production and degradation 
of I(1 ,4 ,5 )P3 has been extensively studied and this has led to the 
discovery of a number of inositol phosphates, including
1,3,4,5-tetrakisphosphate in rat cerebral cortical slices (IP4 )(Batty 
et al., 1985; Irvine et al., 1986). The rapid metabolism of IP4 , as 
well as its rapid formation after receptor stimulation has led to 
debate over its possible role as a second messenger. The role of IP4  
is as yet unclear, however many agonists can promote a slow influx of 
external Ca2+ in addition to mobilising internal Ca2+ and both IP4  and 
IP3  have been implicated in controlling this. In some tissues IP4  may
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control the transfer of Ca2+ between intracellular pools (Irvine & 
Moore, 1986; Berridge, 1987) and in so doing, alter the influx of Ca2+ 
into the endoplasmic reticulum from the extracellular space by an as 
yet unknown mechanism, to replace stores.
Fig. 2 shows a simplified diagram of some of the general concepts of 
the hydrolysis of PIP2 *
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Fig. 2. A Schematic representation of the main routes of 
metabolism in the polyphosphoinositide cycle. All inositol 
phosphates are numbered in the D-isomer configuration. R = 
receptor; Gp = G-protein. (Adapted from Berridge & Irvine, 1989).
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Diacylglycerol and protein kinase C
The other primary product of phospholipase C (PLC) stimulated 
hydrolysis of PIP2 is diacylglycerol (DAG) and there is now strong 
evidence that DAG also functions as a second messenger (Nishizuka,
1983).
Under normal conditions, DAG is almost absent from membranes and it
appears only transiently on receptor stimulation. This is due to its
rapid phosphorylation to phosphatidic acid (PA) by diacylglycerol
kinase and thence conversion back into inositol phospholipids and/or
its further degradation into monoacylglycerol and arachidonic acid by
diacylglycerol lipase (see Nishizuka, 1986). The diacylglycerol
produced in response to receptor occupation initiates the action of a
protein kinase C, so that information from extracellular signals can
be translated directly across the membrane to protein phosphorylation
(Nishizuka, 1983). The protein kinase C identified for this process
requires calcium, acidic phospholipids (especially phosphatidylserine,
however phosphatidylcholine exerts a negative effect) and DAG for
maximum activity (Nishizuka, 1984). DAG greatly increases the
affinity of the protein kinase for Ca^+ , so that in the presence of
DAG, maximum activity of the kinase occurs at basal cytosolic
? +concentrations of Ca^ .
Protein kinase C is found in various tissues in mammals and other 
eukaryotic organisms (Kuo et al., 1980). In unstimulated cells it
exists in the cytosol, however on activation of the cell receptors,
Phosphorylation of myosin light chain may lead to conformational changes of 
myosin light chain, similar to those evoked by myosin light chain kinase (MLCK) and 
hence bring about contraction directly (Kamm et a l.. 1989). Phosphorylation of MLCK 
by PKC, may alter the sensitivity of MLCK to calcium, evoking the activation of MLCK 
at resting cell calcium levels, similarly leading to a contraction as a result of PKC 
activation (Sinaer et al.. 1989).
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production of DAG allows PKC to bind to phosphatidylserine at the 
plasma membrane and it is this that shifts the calcium dependence of 
PKC from high (10"5 -10“4 M) to low (<10“6 M) concentrations, thereby 
activating the kinase.
Protein kinase C can also be activated by synthetic diacylglycerols 
or tumor-promoting phorbol esters such as phorbol 1 ,2 -myristate
1 ,3 -acetate (PMA), which possess a DAG-like structure (Castagna et 
al., 1982). The action of phorbol esters lasts however for hours, 
while that of DAG is transient.
Once activated, PKC phosphorylates a large number of proteins
including smooth muscle myosin light chain (Naka et al., 1983;
Nishikawa et al. , 1983) and myosin light chain kinase (Nishikawa et
ft
al., 1984; Ikebe et al. , 1985). PKC may also modulate ion conductance 
by phosphorylating ion channels, pumps and ion exchange proteins 
(Nishizuka, 1986). It may also have a role in extrusion of calcium 
immediately after its mobilization into the cytosol (e.g. via a 
voltage-dependent Ca2+ channel or by the actions of IP3 / Drummond, 
1985; Albert & Tashjian, 1985) and the Ca2+ transport ATPase is also a 
possible target of this protein kinase (Limas, 1980; Iwas & Hosey,
1984).
Alternative sources of 1,2-diacylglycerol
While production of DAG from hydrolysis of PIP2 is now well 
documented, it has become apparent that the phosphatidylinositols are 
not the only source of DAG.
Following the suggestion by Bocckino et al. (1985) that hormonally 
induced-DAG was partially derived from sources other than inositol 
phospholipids, Exton (1988) concluded that the generation of DAG from 
phosphatidylcholine exceeded that from PIP2  hydrolysis in isolated 
hepatocytes. Phosphatidylcholine is found almost exclusively in 
eukaryotic cell membrane and forms the largest part of the cell 
membrane. Evidence for the role of phosphatidylcholine (PC) in DAG 
production is now fairly conclusive in isolated cells preparations. 
The evidence in favour of a receptor-regulated choline phospholipid 
hydrolysis is based on the following observations. Activation of 
various receptors has been shown to enhance the release of choline, 
phosphocholine and glycerophosphocholine - each metabolites of PC 
(Besterman et al. , 1986; Cabot et al., 1988a; 1988b; Welsh et al.,
1988). The fatty acid composition of the evoked DAG and phosphatidic 
acid (PA) was closer to that of phosphatidylcholine than of 
phosphatidylinositol The amount of DAG or PA formed in response to 
stimuli often exceeded the release of inositol phosphates (Bocckino et 
al., 1985). The only phospholipid that declined was in many cases
phosphatidylcholine (Bocckino et al., 1987) and while Pl-phospholipase 
C is blocked in zero external calcium (Uhing et_alJL, 1986), PA
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accumulation due to PC hydrolysis was not (Bocckino et al., 1987).
The pathways proposed for the hydrolysis and synthesis of 
phosphatidylcholine (PC) are shown in fig. 3. There are three 
phospholipases by which DAG may be produced from PC, phospholipase C 
(PLC), phospholipase D (PLD) and phospholipase A 2  (PLA2 ).
In contrast to the phospholipase C catalyzed hydrolysis of PIP2 / the 
hydrolysis of PC produces DAG without altering cytoplasmic levels of 
Ca2+. As previously discussed however, DAG produced from PC can still 
propagate a signal by enhancing the affinity of PKC for available Ca2+ 
and thereby activating the kinase.
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Fig. 3. Phosphatidylcholine cycle for generation of diacylglycerol 
(DAG). DAG can be generated directly via phospholipase C (PLC), or by 
the action of phospholipase D (PLD) to yield phosphatidic acid (PA) 
which is cleaved to DAG by PA phosphohydrolase (PAP). Alternatively, 
DAG may be formed from PA generated by the actions of phospholipase A 2  
(PLA2 ), in which case, arachidonic acid, the precursor or the 
eicosanoids is also produced. DAG can react with CDP-choline, formed 
by the action of phosphocholine cytidylyltransf erase (CT) on 
phosphocholine, to complete the PC turnover cycle. (Reproduced from 
Pelech Sc Vance, 1989)
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The mechanisms of action of the two transmitters NA and ATP may 
involve at least two of the above mentioned types of transduction 
mechanisms, 1), 2) and 3).
Some indication of the importance of the first above mentioned 
receptor-effector mechanism has been obtained by examining the effects 
of ATP and NA on the resting membrane potential of smooth muscle cells 
and the associated contraction.
Stimulation of sympathetic nerves supplying smooth muscle may, for 
example in rabbit saphenous artery (Holman & Surprenant, 1979), evoke 
junction potentials (e.j.p.s), which represent a rapid shift in 
membrane potential, such that the entry of calcium into the cell 
through voltage-sensitive calcium channels is likely to be increased 
(Bolton & Large, 1986), leading, in many cases, to action potential 
and contraction. In some cases, the fast e.j.p.s are followed by a 
slow depolarisation (e.g. rat tail artery, Cheung, 1982) which is 
easier to observe after a train of stimuli (Bolton & Large, 1986) and 
may similarly be associated with a contraction.
Use of antagonists has allowed separation of the components of the 
electrical and mechanical responses to NA and ATP released during 
nerve stimulation and it has become apparent that the degree to which 
each of these transmitter utilises voltage-dependent mechanisms, 
varies among different tissues.
Thus in the rabbit ear artery (Allcorn et al^, 1985), field 
stimulation of intramural nerves evokes e.j.p.s followed by a slow
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depolarisation and a contraction. The evoked e.j.p.s are mediated by 
ATP, as evidenced by the use of the desensitising agent ap MeATP. 
Electrically, NA produces only the slow depolarisation yet is 
responsible for the entire mechanical response, which is abolished by 
prazosin. In the rabbit mesenteric artery (Lim et al., 1986), nerve
released NA does not alter the membrane potential, while ATP produces 
e.j.p.s which summate to produce action potentials. The contraction is 
mediated by both ATP and NA. Similarly, there are many examples (e.g. 
rabbit ear artery, Droogmans et al., 1977; rabbit saphenous artery, 
Holman & Surprenant, 1979) where addition of exogenous ATP produces a 
depolarisation whilst exogenous addition of NA does not. By contrast, 
in the rat mesenteric artery (Mulvaney et al., 1982), contractions to 
exogenously added NA are accompanied by membrane depolarisations.
It seems likely therefore that in many smooth muscles, the 
co-transmitter ATP acts via a voltage-dependent mechanisms to produce 
contraction. There is however evidence (Benham & Tsein, 1987) that in 
the rabbit ear artery, ATP mediates its effect, not only via voltage 
dependent Ca^+ channels, but also via voltage-independent channels 
which are operated directly by ligands, in the absence of any change 
in second messengers. This may constitute an example of the second 
type of mechanism listed above.
It has been proposed that in some arteries e.g. the rabbit mesenteric 
artery (Nelson et a l . , 1988) that NA similarly acts via
voltage-dependent Ca^+ channels. In many cases however, NA produces 
only small electrical changes which appear insufficiently large to be 
underwritten by substantial ion changes. The contractile basis for NA
must, to a large degree, involve those mechanisms where cellular
events do not rely on extracellular ion movements, but which are
mainly concerned with providing calcium from intracellular stores, or 
with altering the sensitivity of the cell to resting calcium. NA is
more likely therefore to utilise the last of the three mechanisms
described above, i.e. where the receptor and ion channel are linked 
via a G-protein and enzyme system. Indeed, the PIP2 cycle has now 
been shown to be activated by NA in a number of vascular tissues, e. 
g. rabbit mesenteric artery (Hashimoto et al., 1986), rat tail artery 
(Fox et a l . , 1985) rabbit aorta (Campbell et al. , 1985) and rat aorta 
(Legan et a l . , 1985). Stimulation of PC hydrolysis has not yet been
shown for noradrenaline.
The possibility that, in addition to acting via voltage-operated ion 
channels, ATP may also stimulate PIP2 hydrolysis has been less often 
studied. There is some evidence however, that in rat tail artery 
(Jenkinson, 1990) in addition to producing e.j.p.s, ATP may also 
stimulate PIP2  hydrolysis. ATP has also been shown to stimulate PIP 
hydrolysis in a number of cell lines, including hepatocytes (Charest 
et al, 1985) and Ehrlich ascites tumor cells (Dubyak, 1986). ATP has 
similarly been implicated in the receptor mediated hydrolysis of PC in 
isolated hepatocytes (Bocckino et a l ., 1987). The question of whether 
the ATP stimulated PIP2  or PC hydrolysis precedes, or is a consequence 
of the electrical changes in the smooth muscle cell has yet however to 
be answered.
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Within the mechanisms of signal transduction described, synergism 
and/or reciprocation is possible on several levels. First, the 
possibility exists of a multiple effect of the second messengers 
released as a result of PIP2  hydrolysis. IP3 so formed will mediate 
release of calcium from the endoplasmic reticulum, as well as 
controlling - possibly along with IP4  - the influx of extracellular 
Ca2 + . DAG will stimulate protein kinase C by enhancing its sensitivity 
to Ca2 + . This may further evoke changes in Ca2+ levels by the 
PKC-mediated phosphorylation of channels, or by kinase effects on Ca2+ 
sequestration, as discussed above.
Secondly, there exists the possibility of an interaction between 
elevated calcium levels, resulting from a voltage-dependent mechanism 
(e.g. e.j.p.s produced by ATP) and DAG mediated activation of PKC 
(produced by a voltage-independent mechanism, such as is proposed to 
explain the action of NA in many tissues). Evidence for interactions 
of these types is already available, in a variety of isolated cells, 
from the concomitant use of calcium ionophores such as A23187 to raise 
calcium levels and phorbol esters to stimulate PKC e.g. in platelets 
(Kaibuchi et al., 1983), lymphocytes (Rink et al., 1983) and 
hepatocytes (Mastro & Smith, 1983). In most of these studies, neither 
component alone produces the maximal physiological response, but do so 
only when they are together. Thus voltage-independent mechanisms may 
reinforce or synergize with the voltage-dependent mechanisms inherent 
in the e.j.p.s - commonly produced by ATP - in a co-transmission 
system, providing a basis for a 1 dual-control 1 mechanism.
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AIMS OF THE THESIS
The emergence of the concept of co-transmission in both the 
parasympathetic and sympathetic nervous system has provided a
potential degree of complexity in autonomic control of muscle,
hitherto not encountered.
Co-transmission therefore provides a challenge to pharmacologists to 
unravel the means by which the transmitters concerned operate to
achieve the physiological response. Just as drug control of
cholinergic and noradrenergic responses has had clinical uses, the 
possibility exists that once the mechanisms of action of
co-transmitters are fully understood, manipulation of multiple
transmitters will have similar clinical ramifications.
Much work has been done to establish the means by which 
co-transmitters operate in producing a physiological response. This 
thesis represents an attempt to do this by studying transmitter
mediated events in a vascular site - the rabbit saphenous artery
-where co-transmission is believed to operate.
Much of the information on the action of co-transmitters has been 
gained from mechanical recordings with the accompanying limitations on 
the interpretation of the underlying mechanisms producing the 
contraction. Accordingly in this thesis, mechanical recordings were 
accompanied by intracellular micro-electrode and biochemical recording 
techniques, to investigate the mechanisms underlying the contractions 
evoked by the released transmitters. In particular, this thesis aimed 
to investigate whether both transmitters evoked similar, or different 
types of cellular change on interaction with their separate receptors
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and if different cellular changes were evoked by each transmitter, at 
what level these transmitter substances interact.
In addition, studies in the canine heart and femoral vascular bed 
were undertaken, to establish the nature of the purine receptor 
subtypes for adenosine, mediating respectively, bradycardia and 
vasodilation in the dog.
MATERIALS AND METHODS
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Tissues for mechanical, intracellular or biochemical recording were 
removed from animals as quickly as possible, as described below. 
Tissues were left for a minimum of 30 min after being set up before 
the start of each experiment. Sodium oleate and antagonists, with the 
exception of staurosporine, were added to tissues 15 min before their 
effects were investigated. Staurosporine and phorbol 1,2-myristate
1,3-acetate (PMA) were each added lh before investigation.
I. DISSECTION OF TISSUES
A. RABBIT SAPHENOUS ARTERY
Male New Zealand White rabbits 1.3-2.5Kg, were killed either by CO2  
"overdose or by a blow to the head. In each case, exsanguination 
followed. Saphenous arteries were removed by a method similar to that 
of Holman & Surprenant (1979). The leg was stripped of skin and 
attached fur and a 3-5cm length of artery dissected from above the 
ankle to below the knee. The artery was then transferred to an 
oxygenated, Krebs-filled petri dish the base of which was coated with 
Sylgard (Dow-Corning) and, at room temperature under a dissecting 
microscope, cleaned of fat and connective tissue .
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B. RAT TAIL ARTERY.
Male albino Wistar rats (200-400g) were killed by a blow to the head 
followed by exsanguination. The tail was severed approximately 1cm 
from the body and removed to an oxygenated, Krebs-filled petri dish, 
the base of which was coated with Sylgard. The cornified epithelium 
was removed and a 3-5cm length of artery dissected out from the 
proximal end of the tail (Holman & Surprenant, 1979). Under a 
dissection microscope, the artery was then cleaned of fat and 
connective tissue.
II. APPARATUS & TECHNIQUES
A. MEASUREMENT OF CONTRACTILE ACTIVITY.
To measure contractile responses from in vitro preparations, 0.5-lcm 
lengths of rabbit saphenous artery were mounted horizontally in a 
heated (37 ± 0.5°C) organ bath (10ml) and bubbled with 95% 0>2 & 5% CO2  
in a modified physiological Krebs solution. The tubing carrying the 
Krebs solution and the organ bath were surrounded by a jacket 
containing water at 42 ± 0.5°C, pumped by a tempette (TE7) pump, to 
maintain the Krebs in the organ bath at 37 ± 0.5°C.
Segments of arteries were mounted under lg tension by placing two 
platinum wires into the lumen. One was attached to a force 
displacement transducer (Grass FT03C) to monitor tension, while the 
other was fixed. Ag/AgCl electrodes were placed parallel to the artery 
segment and stimulation of intramural nerves carried out using an
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isolated square wave stimulator (Grass SD9, 0.5mS, supramaximal
voltage, l-64Hz). The parameters used ensured that no direct 
stimulation of muscle occurred. Contractile activity was displayed on 
a heat sensitive linear chart recorder (Electromed MX216).
Drugs were added to the organ bath in volumes of 0.1 - 0.3ml from
graduated syringes, or using a Gilson pipetman of suitable size. 
Agonists were kept in contact with the tissue for lmin. The organ 
baths were emptied from below and filled from above by gravity. Where 
appropriate, drugs were washed out by emptying and filling the bath 
three times and 5 min were allowed between each addition. For 
continuous or long term infusion, drugs were added to the reservoir to 
give the final concentration required.
B. SIMULTANEOUS INTRACELLULAR ELECTRICAL AND MECHANICAL RECORDING
The electrical and simultaneous mechanical responses of the rabbit 
saphenous artery to field stimulation of intra-mural nerves and to 
drugs, were investigated using intracellular microelectrode and 
conventional mechanical recording techniques in vitro
The apparatus (Fig 4) consisted of a horizontal organ bath (5cm x 1cm 
x 1 cm) cut from a perspex block, the base of which was coated with 
Sylgard, two Ag/AgCl ring electrodes, an indifferent Ag/AgCl 
electrode, capillary glass microelectrodes, D.C. preamplifier, dual 
beam oscilloscope, voltmeter, transducer, isolated stimulator and 
gated pulse generator, U.V. oscillograph1and a tape recorder.
Recording
micro-electrode
To force
displacem ent
transducer
Ejection
micro-pipette
Sylgard base
Saphenous artery
Stimulating
electrodes
Fig. 4 Organ bath for simultaneous mechanical and intracellular 
electrical recordings of the rabbit saphenous artery. A  trough (5cm x 
lcm x 1 cm) was cut from a perspex block, which was drilled to accept 
inlet and outlet tubes (0 .2 cm diameter) for continual perfusion of 
Krebs solution. Tissues were passed through Ag/AgCl (V+-V~) ring 
electrodes attached to a square wave isolated stimulator. One end was 
cut open, flattened and pinned onto Sylgard, while the other was cut 
into a spiral and attached to a force displacement transducer under lg 
tension, for measurement of contractions. Membrane potential changes 
were recorded using conventional glass microelectrodes in response to 
field stimulation and exogenous agonists, applied locally from a 
micro-pipette linked to a pressure-controlled ejection device 
(Picospritzer II). The bath was perfused with oxygenated, heated (37 ± 
0.5°C) Krebs solution, pumped by a tempette (TE7) pump.
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Lengths of artery (2cm) were cleaned of fat and connective tissue as 
described. The artery was cut into a spiral along half its length, 
while the other half was opened lengthwise. The artery was then
placed in the organ bath and constantly perfused (5 ml/min) via two 
inlets, with Krebs solution at 37 ± 0.5 °C, pre-bubbled with 95% 0 2  & 
5% C02 . Emptying of the bath was by suction applied from a water pump. 
Polythene tubing (O.D. 2mm) containing Krebs solution was surrounded 
by an outer tube (O.D. 10mm) containing liquid paraffin at 42 ± 0.5°C, 
pumped by a Tempette (TE7) pump to maintain Krebs at the constant
required temperature.
To minimise mechanical vibrations, the organ bath was bolted to two 
non-conducting Bakelite pillars fastened to a steel plate (200Kg) on a 
table mounted on Mufflite (K-150) anti-vibration dampeners.
The spiralled end of the artery was attached to a force displacement 
transducer (Grass FT03C) and the other end passed through the bipolar 
Ag/AgCl ring electrodes (O.D. 2mm, 2mm apart, mounted in epoxy resin 
(Araldite)) and pinned flat on the Sylgard, serosa uppermost. Field 
stimulation was carried out via an isolated square wave stimulator 
(Grass SD9, 0.5mSec, supramaximal voltage, 0.2-64Hz).
Intracellular recordings were made from cells impaled using glass 
capillary microelectrodes (Clark, GC 150-10, 40 - 80 MS2) filled with 
filtered KCl (3M). Signals were passed to a unity gain high impedance 
(10-*-0q ) DC preamplifier (Neurolog NL 102) via a Ag/AgCl half-cell
attached to a probe, matched and calibrated for the amplifier used.
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The indifferent Ag/AgCl electrode was fixed to the wall of the bath 
and held in the bath solution. Mechanical signals were amplified via a 
low pass filter/amplifier (made by Mr J.Sinclair, Institute of 
physiology, University of Glasgow). Signals were displayed on a 
storage oscilloscope (Telequipment DM63) and displayed on a digital 
voltmeter (Fairchild M53). The electrical and mechanical signals were 
stored permanently on an instrumentation tape recorder (Raccal store 
4DE, band width 313-40kHz) and U.V. Oscillograph (EMI SE3006) Drug 
reached the tissue following;
1) Addition of small bolus quantities by graduated micro-syringe 
(Hamilton), directly to the organ bath
2) Addition as perfusate to give the final concentration required.
3) Local addition by a hydrostatic pressure controlled ejection 
device (Picospritzer II, Gen. Valve Corp., N.J., U.S.A.). Drugs for 
application were filled into ordinary glass micropipettes the tips of 
which had been broken back under microscopic control to 1 - 2  (jm and 
ejected close to the cell from which intracellular recording was being 
made. This technique minimises the possibility of desensitisation of 
receptors by addition of excess drug, while increasing greatly the 
likelihood of obtaining drug responses from the impaled cell.
The amount of drug reaching the recording electrode from the 
picospritzer depended upon the diameter of the tip (l-2 nm), the 
distance of the tip from the recording site (kept to <lmm as measured 
with an eyepiece micrometer), the ejection pressure (held constant at 
40-50 p.s.i.) and the duration of ejection (l-640mS, varied as
indicated in the text).
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C. MEASUREMENT OF CHANGES IN CONDUCTANCE AND RESISTANCE.
Passive membrane properties were measured and changes in membrane 
conductance and resistance under the influence of drugs observed, in 
vitro using the partition method of Abe & Tomita (1968).
The apparatus (Fig 5) comprised an organ bath (5cm x 1cm x 1cm) with 
a sylgard base, cut from a perspex block. The bath was divided into 
two main compartments - for stimulating and recording respectively -by 
means of two silver plate electrodes (50|im thickness x 1cm x 1cm, 1cm
apart). The surface exposed to the recording chamber was coated with
epoxy resin (Araldite) to act as an insulating partition. The
electrodes were connected to an isolated square wave stimulator 
(Devices type 2533) through a resistance (30kQ) to obtain constant 
current. There was a small hole (0.3mm) in each of the plates through 
which the tissue was passed, to be pinned flat in the recording 
chamber.
Relative current intensity was measured from the voltage gradient of 
the solution in the stimulating chamber via two Ag/AgCl recording 
electrodes 2mm apart in the chamber wall. Field stimulation of 
intramural nerves was carried out by two Ag/AgCl ring electrodes in 
the recording chamber, attached to an isolated square wave stimulator 
(Grass SD9, 0.5mS, supramaximal voltage, 1Hz) and intracellular
microelectrode recordings were obtained from within the recording 
chamber, using glass capillary microelectrodes (Clark, GC 150F-10, 
40-80MQ). Both chambers were independently perfused with Krebs 
solution pre-bubbled with 95% 02 , 5% C02 , pre-heated to 37 ± 0.5°C.
The polythene tubing
Recording chamber
Glass micro-electrode
K S h '
Stimulating chamber
Krebs
soln.
+ •  Krebs
— soln.
Saphenous artery
Stimulating electrodes
Fig. 5 Modified Abe & Tomita (1968) partition bath used in the
investigation of membrane conduction, resistance and passive 
electrical properties in the rabbit saphenous artery.
Two Ag plate electrodes divided an organ bath (5cm x 1cm x 1cm) 
into both a recording and a stimulating chamber. The tissue was 
anchored at one end, then passed through a small hole in each of 
the plate electrodes and pinned onto Sylgard in the recording 
chamber, where changes in membrane potential were measured 
intracellularly using glass microelectrodes. Current was applied to 
the muscle via the Ag plate electrodes which were connected to an
isolated square wave stimulator. The relative current intensity was
measured from the voltage gradient of the Krebs solution in the 
stimulating chamber via two Ag/AgCl electrodes. Field stimulation 
of intramural nerves was via two Ag/AgCl ring electrodes situated 
in the recording chamber. Each chamber was separately irrigated 
with oxygenated, heated (37 ± 0.5°C) Krebs solution pumped by a
tempette (TE7) pump.
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(O.D. 2mm) carrying the Krebs solution was surrounded by outer tubing 
(O.D. 10mm) containing liquid paraffin at 42 ± 0.5°C to maintain the 
required temperature.
Drugs were added to the Krebs in the perfusion reservoir.,
D. MEASUREMENT OF THE PRODUCTS OF PHOSPHATIDYLINOSITOL -4,5
BISPHOSPHATE (PIP2 ) HYDROLYSIS)
The involvement of PIP2 hydrolysis in the mechanical response to 
agonists in vitro was assessed by radiochemical measurement of 
inositol phosphates released from segments of rabbit saphenous and rat 
tail arteries incubated with myo-[2--%]-inositol.
Ion exchange resin (Dowex 1 x 8-400, Chloride form) was prepared by
washing with the following solutions; distilled water (11), NaOH (2M, 
21), distilled water (21), formic acid (2M, 0.21), followed by
distilled water until pH 4.5 - 5 was obtained. Aliquots (1ml) of the 
formate form of resin so produced were added to Pasteur pipettes 
(5 ml), serving as chromatography columns, the tips of which were 
plugged with glass wool. Columns were prepared by washing with 
ammonium formate (2.4M, 15ml), followed by distilled water (15-29ml) 
until pH 4.5 - 5 was once again obtained.
The products of PIP2  hydrolysis were examined using a modified 
version of the method of Akhtar & Abdel Latif (1986)
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Segments (l-2mm) of arteries were incubated in glass vials (3ml), for 
3h in Krebs solution containing 8 pCi/ml myo-[2-3 H] inositol at 37 ±
0.5°C and bubbled with 95% C>2 , 5% CC^. Constant temperature was
maintained by immersion of the glass vials in a bath containing water 
at 40 ± 0.5°C, pumped by a tempette (TE7) pump. Tissues were then
further incubated in Krebs solution containing the same quantity of 
myo-[2-JH] inositol, but with the substitution of lOmM NaCl, with lOmM 
LiCl, to inhibit inositol phosphate phosphatase (IP phosphatase) and 
hence prevent inositol phosphate being broken down to inositol and 
subsequent cycling of the phosphatidylinositol (PI) cycle (Hallcher & 
Sherman, 1980). Tissues were then washed twice in fresh Li+ 
substituted Krebs solution and drugs added, by graduated syringe, 
direct to the vial.
Agonists were left in contact with the tissue for 25min and 
antagonists were added 15 min prior to agonists. The reaction was then 
stopped by plunging the tissue into ice-cold trichloroacetic acid 
(TCA, 1ml, 10%) in a glass test tube (5ml). Tissues were homogenised 
in the TCA, using a hand held glass pestle homogeniser, then 
centrifuged at 2,000g for 15 min at 5°C. The supernatant, which now 
contained all soluble compounds, was decanted off for analysis and the 
pellet discarded. Any residual TCA was removed by extraction 3 times 
with water saturated diethyl ether (3ml) and excess diethyl ether 
driven off by placing the tube in a heated water bath at 100°C for 
5min. The remaining supernatant was neutralised with 0.1M NaOH and the 
neutralised extract was then applied to the previously prepared 
columns for separation of the constituents of the samples by a method 
similar to that of Downes et al., (1986).
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The columns were washed with 10ml each; distilled water to - elute 
[3 H]-inositol, Sodium borate (5mM) plus sodium formate (60mM) to elute 
glycerylphoryl inositols, ammonium formate (0.2M) plus formic acid 
(0.1M) to elute [3 H]-Inositol phosphate (IP), ammonium formate (0.4M) 
plus formic acid (0.1M), to elute [3 H]-inositol bisphosphate {IV2), 
and finally ammonium formate (1.2M) plus formic acid (0.1M), to elute 
[3 H]-inositol trisphosphate (IP3 ) and [3 H]-inositol tetrakisphosphate 
(IP4 ) together since separation of these two components was not 
possible. In each experiment, columns were calibrated using standard 
samples of inositol, IP, IP2 ' -^3 an(  ^ ^ 4  confirm the elution 
profile.
A  sample (1ml) of each eluate was added to scintillation fluid (10ml, 
Ecoscint) and total radioactivity determined by liquid scintillation 
counting (Hewlett-Packard 2000CA Tri-carb). Total inositol phosphate 
levels (tIP) were taken as the sum of the amounts of IP, IP2 , IP3  and 
IP4  obtained. Results were adjusted for the whole sample and 
translated to degradations per minute (d.p.m.) per mg of tissue (wet 
weight).
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E. EXTRACTION AND ANALYSIS OF THE PRODUCTS OF PHOSPHATIDYLCHOLINE 
(PC) HYDROLYSIS
The involvement of PC hydrolysis in the mechanical response to 
agonists in vitro was assessed in the rabbit saphenous artery by 
measurement of the breakdown products released from tissues incubated 
with [3 H]-methyl choline.
Columns were prepared by washing ion exchange resin (Dowex, 50-WH+ ) 
extensively with HC1 (1M, 41) followed by distilled water (41), until 
pH 5.5 was obtained. Aliquots (1ml) of the prepared resin were added 
to glass wool-plugged Pasteur pipettes (5ml).
The products of hydrolysis of PC were examined using a modification 
of the method of Cook & Wakelam (1989).
Lengths of rabbit saphenous artery (4cm) were incubated in Krebs 
containing 2pci/ml [3 H]-methyl choline for 18 hours in glass vials 
(3ml); this being the time which allowed the tissue to come closest to 
isotopic equilibrium without significantly impairing the contractile 
response. After incubation, tissues were washed twice in fresh Krebs 
solution and drugs added. The reaction was stopped after the required 
time, by immersing the tissue in ice cold methanol (1ml). Tissues 
were left for lh in methanol, before chloroform and distilled water 
were added to give a final ratio of methanol : chloroform : water of 
1:1:0.9. Tissues were homogenised in a hand held glass pestle 
homogeniser and centrifuged at 2,000g for 15 min at 5°C. The upper
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aqueous phase was taken for analysis. Samples were diluted (to 5ml) 
and loaded onto the prepared columns. Samples were then further eluted 
with a distilled water (4ml), which was added to the initial run off, 
followed by HCl (10ml of 0.01M and finally 20ml of 1M) to elute 
respectively, glycerophosphocholine (GPC), phosphocholine (ChoP) and 
choline (Cho). In each experiment, standards were loaded onto separate 
columns to check the elution profiles.
F. IN VIVO MEASUREMENT OF HEART RATE (HR) AND HIND LIMB PERFUSION 
PRESSURE (HLPP)
Female Beagle dogs (12-15Kg) were anaesthetized with sodium 
pentobarbitone (45-60mg/Kg i.v.) to induce deep anaesthesia, and the
animal was ventilated with air delivered by a respirator pump (Palmer 
ideal, s.v.; 170-230ml, rate; 24/min). The following blood vessels
were catheterised; right jugular vein for administration of 
maintenance anaesthesia (pentobarbitone 5mg/ml delivered at 22ml/h); 
the right brachial vein for administration of antagonists; the right 
brachial artery for measurement of systemic blood pressure using a 
pressure transducer (Bell & Howell 4/327/L211) and for blood sampling; 
the left carotid artery for administration of agonists. The catheter 
to the left carotid artery was introduced into the left ventricle to 
administer agonists directly to the heart.
The right hind limb was perfused from the right iliac artery, via a 
perfusion pump (Watson Marlow, 520s) back to the right femoral artery, 
at a constant flow rate (30-40ml/min) and the right leg was tied off
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just above the ankle to isolate the vascular bed of the perfused'limb. 
Perfusion pressure was measured by a (Bell & Howell 4/327/L211) 
pressure transducer.
Both Vagi, the right femoral and the right sciatic nerves were 
ligated and severed and ECG recording electrodes were placed around 
the chest wall. Heart rate measurements were taken from the ECG 
signal.
Each animal was given a bolus injection of the anticoagulant heparin 
(1250u) to prevent blood clotting and the p-p partial agonist 
xamoterol hemi-fumarate (lmg/Kg) to maintain a stable high heart rate 
and so facilitate measurement of drug induced responses. The adenosine 
uptake blocker s-(p-nitrobenzyl)-6 -thioinosine (NBTI, 0.5mg/Kg) was
given to prevent purine uptake and hence maximise the effects of 
adenosine.
Samples of blood were taken for blood gas analysis (Ciba-Corning 278 
blood gas system), any blood acidosis corrected by administration of 
sodium bicarbonate (8.4%w/v). Blood CC>2 and O2  levels were maintained 
by alteration of the tidal volume and animals were allowed to 
acclimatise for one hour before the start of experiments.
Except where otherwise stated, drug addition was by bolus injection 
into the relevant catheter.
At the end of experiments, dogs were sacrificed by intravenous injection of a 
saturated solution (25ml) of KCI.
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III. CRITERIA FOR CELL PENETRATION
A cell was accepted for electrophysiological investigation provided 
the following criteria were satisfied;
(a) the penetration was sharp and the membrane potential stable, 
varying by not more than 2mV
(b) excitatory junction potentials were observed in response to field 
stimulation of intramural nerves
(c) The resting membrane potential was more negative than -60mV
(d) following withdrawal of the microelectrode, the membrane 
potential was restored to the levels observed before penetration.
IV. PHYSIOLOGICAL SOLUTIONS AND CHANGES IN IONIC COMPOSITION
Except where stated, Krebs solution of the following composition (mM) 
was used throughout the investigation. NaCl, 118.4, NaHC02 , 25, 
NaH 2 P04 , 1.13, KCl, 4.7, MgCl2 , 1.3, CaCl2 , 2.7 and glucose, 11.
Where the ionic composition of the Krebs solution was modified, 
isotonicity was maintained by substituting or reducing the 
concentration of another appropriate ion. In K+-free or low K+ Krebs, 
KCl was wholly or partly replaced by NaCl. In solution containing an 
increased concentration of K+ , an equivalent reduction in NaCl was 
made. Na+ deficient solutions were made by substituting NaCl with 
choline chloride. Cl- free solutions were made by substituting NaCl
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with Na benzenesulphonate, KCl with K 2 S04 , MgCl2  with MgS04  and CaCl2
n  i
with CaS04 . Ca^ free solutions were made by substituting CaCl2  with 
MgCl2 . Where Li+ substituted Krebs was required, an equivalent amount 
of NaCl was withdrawn.
The pH of the Krebs solution in each case was maintained at 7.4 by 
gassing with a mixture of 95% 02  and 5% C02 .
V. DRUGS
The following drugs were used:
ap Methylene adenosine 5 1-triphosphate sodium (ap MeATP, Sigma), 
adenosine sodium (Sigma), adenosine 5'-triphosphate sodium (ATP, 
Sigma), atropine sulphate (Sigma), 8 ,8 1-[carbonyIbis
[imino-3,1 -phenylene carbonylimino (4-methyl-3,1 -phenylene)
carbonylimino]]bis -1,3,5-napthalene trisulfonic acid hexasodium 
(Suramin, I.C.I.), N^-cyclopentyl adenosine (CPA, Research
Biochemicals Inc.), desmethylimipramine hydrochloride (DMI, Ciba), 
diltiazem hydrochloride (Sigma), N-[2-(dimethylamino)
ethyl]-N-methyl-4-(2,3,6,7-tetrahydro -2,6 -dioxo-l,3-dipropyl
-lH-purin-8 -yl) benzenesulphonate (PD115199, synthesized by I.C.I.), 
1,3-dipropyl 8 -cyclopentyl xanthine (PD 116948, synthesized by
I.C.I.), 5 1-(N-ethylcarboxyamido) adenosine (NECA, Sigma),
guanethidine monosulphate (Ciba), heparin sodium B.P.(Evans), 
histamine diphosphate (Sigma), 5-hydroxytryptamine hydrochloride 
(5-HT, Sigma), 6 -hydroxydopamine hydrobromide (6 -OHDA, Sigma),
2-(2-(l,4 benzodioxanyl)) 2-imidazoline hydrochloride (Idazoxan,
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Reckitt & Coleman), [^H] inositol phosphate marker set (Amersham 
Int.)/ [^H]-methyl choline chloride (Amersham Int.),
myo-[2-JH]-inositol (Amersham Int.), s-(p-nitrobenzyl)-6 -thioinosine 
(NBTI, Sigma), (-) noradrenaline bitartrate (NA, Sigma), (±) 
normetanephrine hydrochloride (NMN, Sigma), N^-2-phenylamino adenosine 
(PAA, Research Biochemicals Inc.), (+)-N^-(2-phenylisopropyl) 
adenosine, (r-PIA, Research Biochemicals Inc.), 8 -phenyltheophylline 
(Research products Inc.), phorbol 1,2-myristate 1,3-acetate (PMA, 
Sigma), potassium chloride (KCl, Koch-light), (±) prazosin (Pfizer), 
(±) propranolol hydrochloride (Sigma), quinacrine dihydrochloride 
(mepacrine, Sigma), sodium fluoride (NaF, Hopkins & Williams), sodium 
oleate (NaOl, Sigma), sodium pentobarbitone (Sagatal, May & Baker), 
staurosporine (Sigma), tetraethylammonium bromide (TEA, Sigma), 
tetrodotoxin (TTX, Sigma), theophylline (Sigma), trichloroacteic acid 
(TCA, B.D.H. Ltd.). xamoterol hemi-fumarate (Corwin, I.C.I.),
Concentrations in the bath refer to the salts, except TTX 
theophylline and staurosporine, which are expressed as concentration 
of the base.
With the following exceptions, drugs were dissolved in distilled 
water, prior to their dilution in saline (0.9%) to give the required 
final concentration. PD116948, PD115199 and 8 -phenyltheophylline were 
dissolved in polyethylene glycol 400/ sodium hydroxide (0.1M, 1:1,
v/v); NBTI was dissolved in polyethylene glycol 400/saline 0.9% (1:1 
v/v); PMA was dissolved in 95% ethanol; PIA and staurosporine in 95% 
ethanol/distilled water (1:1 v/v). Dilutions were made in saline
(0.9%) as before. In each case, controls used vehicle alone.
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VI. ANALYSIS OF RESULTS
Results were expressed as mean ± standard error of the mean (s.e.m.), 
n = number of observations. Students t-test or one way analysis of 
variance were used to test for significance between means. A t -  value 
of p<0.05 was taken as being significant.
Characteristic, individual examples from electrophysiological 
experiments, have been chosen to present most significant findings. 
Three or more tissues were used to investigate each drug or parmeter 
and each tissue provided several cells. The 'n' values given represent 
the total number of cells from which recordings were made.
In most electrophysiological studies undertaken in the present work, 
the experimental arrangement permits simultaneous electrical recording 
from'one cell and mecahnical recording from the entire tissue, however 
in experiments using a Picospritzer, mechanical recordings cannnot be 
obtained, due to the very small number of cells stimulated by this 
method.
RESULTS
pg.92
I. RESTING MEMBRANE CHARACTERISTICS
oV At* rc^ =,vX OrW^
The resting membrane potential^ranged from -59mV to -8 6 mV, with a
mean value of -69.39 ± 0.26mV (n=250). The resting membrane potentials 
formed a population with normal distribution, giving evidence of only 
one population of cells (Fig. 6 )
Spontaneous excitatory junction potentials (s.e.j.p.s) 2-6mV
amplitude (mean 3.5 ± 0.6mV, n=45) were observed in over 95% of cells 
examined. They occurred singly, infrequently (every 3 - 1 0  min) and at 
irregular intervals.
II. PASSIVE ELECTRICAL PROPERTIES
The passive membrane properties of the smooth muscle cells of the 
rabbit saphenous artery were investigated using the techniques of Abe 
& Tomita (1968). Using the apparatus previously described, rectangular 
pulses of constant inward (hyperpolarising) or outward (depolarising) 
current were applied (for 5sec) to the tissue. Electrotonic potentials 
produced in response to this stimulation, were recorded 
intracellularly from the outer layer of the artery, via glass 
microelectrodes in the recording chamber, held at several distances 
(0.5-3mm) from the stimulating plate electrodes. For both depolarising 
and hyperpolarising stimuli, the amplitude of the electrotonic 
potential was linearly proportional to the stimulus intensity and 
rectification was not apparent over the ranges studied (Fig. 7).
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Fig. 6. Resting membrane potential plotted against the number of 
cells shows a normal distribution about the mean (69.3 ± 0.26mV),
with no evidence of more than one cell type.
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Fig. 7. Current (V/cm)/ voltage (mV) relationship in rabbit 
saphenous artery measured using the Abe & Tomita (1968) partition 
bath technique. Recordings of electrotonic potentials evoked by 
graded stimuli (square wave pulses, 5s duration), were taken 
intracellularly at 0.5, 1.5 and 2.25mm from the stimulating plate 
electrodes. No rectification was observed in response to inward 
(depolarising) or outward (hyperpolarising ) currents over the 
range used.
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Electrotonic potentials could be measured up to 4mm from the 
stimulating plate electrode. The amplitude of the transmembrane 
electrotonic potential to a uniform hyperpolarising or depolarising 
stimulus, decayed exponentially with increasing distances of recording 
site from the stimulating plate electrode. From the slope of semi-log 
plots of these two parameters (amplitude against distance), the mean 
space constant (A = 0.42 ± 0 .1 2 mm, n= 1 2 ) was calculated, Fig. 8 ).
III. RESPONSE TO FIELD STIMULATION
(A) EVOKED MEMBRANE ACTIVITY
Field stimulation (0.5msec, supramaximal voltage, single pulse or 
trains of pulses at l-64Hz) of the intramural nerves of the rabbit 
saphenous artery evoked, in the absence of drugs, an electrical 
response which consisted solely of excitatory junction potentials 
(e.j.p.s). Single pulses evoked e.j.p.s ranging from 2-18mV in 
amplitude (mean 6.7 ± 0.3mV, n=115), with duration of around 500msec 
(mean 489 ± 17msec, n=35). Trains of pulses evoked e.j.p.s which
facilitated (at or above 0.5Hz) and summated (above 2Hz) to reach a 
maximum of 20mV. These e.j.p.s often had an uncommonly sharp or 'peaky 
shape (see Holman & Surprenant, 1979) (Fig. 9). Prolonged stimulation 
(4Hz for lmin) failed to uncover any additional electrical event. 
There was no accompanying late slow membrane depolarisation, nor were 
action potentials observed in untreated tissues with any stimulation 
parameter.
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Fig. 8 . Estimation of the length constant ( A )  f°r the rabbit 
saphenous artery was obtained from the slope of a semi-log plot of 
the amplitude of electrotonic potential (ordinate mV) evoked by a 
uniform depolarising or hyperpolarising pulse, against distance 
from the stimulating electrode (A = 0.42 ± 0 .2 1 , n= 1 2 )
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Field stim. (•)
r-58mV68mV
SS 1Hz
]  75mg
2Hz 4Hz
2s
Fig. 9. Electrical (upper trace in each case) and 
simultaneously-recorded mechanical responses to field stimulation 
(•, 0.5msec, supramaximal voltage, single stimulus and trains of 
pulses at 1, 2 and 4Hz) of the rabbit saphenous artery. Single 
stimulus evoked e.j.p.s and, on occasion, contractions. Trains of 
pulses evoked discrete e.j.p.s which facilitated (>lHz), summated 
(>2Hz) and were accompanied by monophasic contractions. 
Intracellular microelectrode recordings were made from the same 
cell.
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Infusion of TEA (5xl0“^-10“^M, Fig. 10), a substance which blocks 
certain potassium channels (Imaizumi & Watenabe, 1981), produced no 
significant change in the resting membrane potential of the rabbit 
saphenous artery but increased the amplitude of evoked e.j.p.s to a 
mean value of 15.2 ± 0.8mV, (n=15, range 10-25mV). In the presence of 
this drug, action potentials (32-40mV) were seen superimposed on 
depolarisations of 12mV or more in response to single pulses or trains 
of stimuli.
The action potentials thus produced were abolished by the calcium 
channel blocking drug, diltiazem (10“-%). Diltiazem failed however to 
alter the amplitude of the evoked e.j.p.s. in the presence of TEA.
(B) EVOKED MECHANICAL ACTIVITY
Trains of pulses (0.5msec, supramaximal voltage, l-64Hz) and on 
occasion single stimuli, (0.5msec, supramaximal voltage), produced 
fast monophasic contractions (Fig. 9). In the presence of TEA, the 
evoked contraction was greatly increased (Fig. 10).
IV. EFFECTS OF ALTERATION OF EXTERNAL ENVIRONMENT
The underlying ionic basis for the electrical response to intramural 
nerve stimulation was examined by changing the external ionic 
environment.
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Fig. 10. Electrical (upper trace in each case) and simultaneously 
recorded mechanical responses to field stimulation (•, 0 .5 msec, 
supramaximal voltage, single stimulus and trains of pulses at 1 , 2 and 
4Hz) in the absence (A) and in the presence (B) of TEA (10“^M). The 
amplitude of the evoked e.j.p.s and the mechanical response were 
enhanced in the presence of TEA. Action potentials were seen 
superimposed on depolarisations of 12mV or more in the presence of TEA. 
Electrical recordings were made from the same cell. Overall the mean 
increase in e.j.p. amplitude and contraction was 226±11.4% and 1154±12% 
respectively (p<0.001, n=15)
(A) POTASSIUM
Removal of external potassium ([K+ ]Q , control 4.7mM) produced no 
significant change in membrane potential (n = 9). During an initial 
period of approximately 30 min, e.j.p.s were unaffected, thereafter 
e.j.p.s were progressively suppressed to approximately 5% of control. 
In a small number of cells, a greatly increased level of frequency and 
amplitude of spontaneous e.j.p.s was observed in the minutes following 
introduction of K+ free Krebs solution, which subsided after 20-30 
min.
The mechanical response to field stimulation (0.5msec, supramaximal 
voltage, l-4Hz) was initially enhanced in K+ free Krebs solution but 
as the e.j.p.s started to decline after 30min, a large mechanical 
oscillation was observed which made measurement of the contraction to 
field stimulation difficult (Fig. 11).
These results suggest that K+ may be involved in production of the 
evoked e .j .p ..
An increase in [K+ ] 0  from 4.7mM (control) to 9.4mM, significantly 
depolarised the membrane (pCO.OOl) from -68.2 ± 0.73mV (n=59) to -59.4 
± 0.55mV (n=62). The amplitude of the evoked e.j.p.s was significantly 
reduced (p<0.005), while the mechanical response to field stimulation 
(0.5msec, supramaximal voltage, l-4Hz) was potentiated, possibly as a 
result of the depolarisation (Fig. 12).
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Fig. 11 The effect on the intracellularly-recorded electrical (upper 
trace in each case) and simultaneously recorded mechanical responses to 
field stimulation (•, 0.5msec, supramaximal voltage, single stimuli and 
trains of pulses at 1 and 2Hz), of removal of [K+ ] 0  (control = 4.7 x 
10”^M). After approximately 30 mins, the evoked e.j.p.s were greatly 
attenuated and a large mechanical oscillation in tone of up to 55mg was 
observed. Intracellular microelectrode recordings were made from the 
same cell. Overall the mean decrease in e.j.p. amplitude was 95±3.2% 
(p<0.001, n=15)
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A Field stim. (•)
• •
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>-68mV
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B Field stim. (•) in [K+]0 -9 x 1 0*3M Krebs soln.
]
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Fig. 12. The effect of doubling [Kt]0 from (A) control (4.7 x 10"%), 
to (B) 9.4 x 1 0 " %  on the electrical (upper panel in each case) and 
mechanical responses to field stimulation (•, 0.5msec, supramaximal 
voltage, single stimulus and trains of pulses at 1, 2 and 4Hz).
Doubling [K+ ] 0  depolarised the membrane, reduced the amplitude of the 
e.j.p.s and potentiated the contractions. Intracellular microelectrode 
recordings were made from the same cell. Overall, the mean reduction in 
e.j.p amplitude and^contraction was, respectively 32±8.4% (p<0.01) and 
24±5.1% (p<0.05), n=14.
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(B) SODIUM
A reduction in external sodium ([Na+ ]0 ) from 144.5mM (control) to 
108.3mM, depolarised the membrane from -69.3 ± 0.68mV (n=40) to -58.6 
± 1.13mV (n=18). Subsequent evoked e.j.p.s (0.5msec, supramaximal 
voltage, l-4Hz) were greatly attenuated (p<0.005). A large transient 
contraction was observed immediately on introduction of the low sodium 
Krebs, which subsided after 5-8min. Thereafter mechanical responses to 
field stimulation were enhanced.
A  further reduction in [Na+ ] 0  to 72.2mM depolarised the membrane 
further, to -54.2 ± 1.73mV (n=9) and abolished evoked e.j.p.s. Again a 
large transient contraction was observed, after which the contraction 
to field stimulation (0.5msec, supramaximal voltage, l-4Hz) was 
abolished (Fig. 13).
These results suggest that sodium is also involved in the evoked 
e.j.p.
(C) CHLORIDE
Removal of extracellular chloride ([Cl“ ]0 ), significantly depolarised 
(p<0.05) the membrane to -58.7 ± 1.73mV (n=15) and substantially
reduced (>90%) or abolished, the evoked e.j.p.s. Contractions to 
field stimulation (0.5msec, supramaximal voltage, l-4Hz) were reduced 
by some 50% (Fig. 14).
(D) CALCIUM
Removal of extracellular calcium ([Ca^+ ]Q ) did not alter the resting 
membrane potential but progressively reduced both the electrical and 
mechanical responses to field stimulation (0.5msec, supramaximal
pg.104
F ie ld  S tim . ( • )
i.. ■ p- 1 N
-6 0 m V
7 0 m V
S S 1 H z 2 H z
B
F ie ld  s t im . ( • )  in [N a +]0 - 7 .2  x  1 0 '2 M K re b s  s o ln .
-5 5 m V
6 5 m V
S S 1 H z
]  7 5 m g
Fig. 13. The effect of* reducing [Na+]Q from (A) control (14.4 x 10"%) 
to (B) 7.2 x 10"% on the electrical (upper trace in each case) and 
mechanical responses to field stimulation (•, 0.5msec, supramaximal 
voltage, single stimulus and trains of pulses at 1 and 2Hz). Reduction 
of [Na+]0 to 50% of control, depolarised.the membrane and abolished 
both the evoked e.j.p.s and mechanical response. Intracellular 
microelectrode recordings were made from the same cell. Total number of 
cells from which recordings were made (n)= 15.
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Fig. 14. The effect of removal of [Cl~]0 on the electrical (upper 
trace in each case) and mechanical responses to field stimulation (•, 
0.5msec, supramaximal voltage, trains of pulses at 1, 2 and 4Hz) in the 
rabbit saphenous artery. The membrane was depolarised and the evoked 
e.j.p.s attenuated or abolished. Contractions were approximately 
halved. Intracellular microelectrode recordings were taken from the 
same cell. Overall, the mean reduction in e.j.p. amplitude and 
contraction was 98.4±0.6% and 54.7±11.1% respectively (p<0.001, n=14).
voltage, l-16Hz), until after 10-15min they were abolished (Fig. 15), 
presumably resulting from an inhibition of transmitter release.
V. THE EFFECT OF DRUGS ON THE EXCITATORY RESPONSE TO FIELD 
STIMULATION
The contractile effect of putative transmitter substances released 
following nerve stimulation in the rabbit saphenous artery have been 
identified as NA and ATP (Burnstock & Warland, 1987). Their electrical 
and simultaneously recorded mechanical effects were investigated using 
agents which antagonise the actions of these two substances.
(A) PRAZOSIN and ap MeATP.
Perfusion with the a^-adrenoceptor antagonist prazosin (lCT^M) had no 
effect on either the resting membrane potential, or the evoked e.j.p.s 
but reduced the mechanical response to field stimulation (0.5msec, 
supramaximal voltage, l-16Hz), by 30-50%. Perfusion of the 
P 2 ~purinoceptor desensitising agent ap MeATP (10-^M), evoked an 
initial depolarisation from -69.3 ± 0.26mV (n=257) to -53.4 ± 1.02mV 
(n=28). The membrane potential however returned to control values 
within 3-5min and recordings in all cases were taken after the initial 
depolarisation had subsided, at which time the tissue was insensitive 
to further bolus addition of ap MeATP (10”^M) and the P2 ~purinoceptors 
were considered desensitised. Subsequent references to desensitisation 
with ap MeATP refer to this process, ap MeATP abolished the evoked 
e.j.p.s as well as reducing by 50-70%, the mechanical response to
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Fig. 15. The effects of removal of [Ca^+]Q on the electrical (upper 
trace in each case) and mechanical responses to field stimulation (•, 
0.5msec, supramaximal voltage, trains of pulses at 1, 2, 4 and 8Hz). 
Removal of [Ca^+j^ abolished all electrical and mechanical activity. 
Intracellular microelectrode recordings were made from the same cell. 
Total number of cells from which recordings were made (n) = 15.
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field stimulation (0.5msec, supramaximal voltage, l-16Hz).
A combination of prazosin and ap MeATP (each 10-6M) abolished both 
the electrical (e.j.p.s) and the mechanical response (Fig. 16).
This suggests that in the rabbit saphenous artery, NA and ATP (or a 
closely related substance) are released following nerve stimulation, 
and mediate effects post-junctionally. The non-adrenergic component 
alone mediates the electrical response via P 2 _purinoceptors, while 
both NA acting via a^-adrenoceptors and ATP (or a closely related 
compound) mediate the contraction.
The lack of electrical response to NA, as evidenced by the results 
from esqperiments with prazosin, was at odds with results found in 
other vascular tissues, such as the rabbit ear artery (Suzuki & Kou, 
1983, Allcorn et al., 1985), where the same substances have been 
proposed as co-transmitters. In that tissue, the e.j.p.s which were 
non-adrenergic were followed by a slow depolarisation attributable to 
NA. Attempts were therefore made to maximise any NA-mediated responses 
in the rabbit saphenous artery.
(B) NORMETANEPHRINE (NMN) and DESMETHYLIMIPRAMINE (DMI)
—6
To maximise any nerve released NA in the synaptic cleft, NMN (10 M) 
and DMI (10~^M) which respectively block NA uptake into non-neuronal 
and neuronal sites were added to the perfusate. In the presence of a 
combination of these drugs, the mechanical response to field 
stimulation (0.5msec, supramaximal voltage, l-16Hz) was greatly 
enhanced, however e.j.p.s were unaffected and no additional electrical
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Fig. 16. The effect in the rabbit saphenous artery on the electrical 
(upper trace in each case) and mechanical responses to field 
stimulation (•, 0.5msec, supramaximal voltage, trains of pulses at 1, 
2 , 4 and 8Hz), of prazosin (10“^M, B) alone and in combination with ap 
MeATP (10“^M, C) , compared to control'(A). Prazosin had no significant 
effect on the e.j.p.s but reduced the contraction overall by 57±8.2% 
(n=15). Prazosin and ap MeATP together abolished both the electrical 
and mechanical responses. Intracellular microelectrode recordings shown 
were taken from two different cells. Total number of cells from which 
recordings were made (n) = 30.
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effects were observed (Fig. 17).
In addition, long periods of stimulation also failed to demonstrate 
any electrical NA response. The role of other receptors in modulating 
the response to the putative transmitters was next examined.
(C) PROPRANOLOL
The presence of (±) propranolol (10-6-10_5M) to antagonise 
p-adrenoceptors, did not alter the resting membrane potential, the 
e.j.p.s or the contraction to field stimulation (0.5msec, supramaximal 
voltage, l-16Hz), indicating an absence of p-adrenoceptor control of 
the neuronal response.
(D) ATROPINE
Atropine (10“^M) likewise had no effect on the resting membrane 
potential, or on mechanical or electrical responses to field 
stimulation (0.5msec, supramaximal voltage, 0.2-16Hz) indicating that 
cholinergic receptors do not modify the neuronal response in this 
tissue.
VI. The origin of the putative transmitter substances ATP and NA
(A) TETRODOTOXIN (TTX)
TTX selectively prevents the increase in sodium permeability
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Fig. 17. Electrical (upper trace in each case) and mechanical 
responses to field stimulation (•, 0.5msec, supramaximal voltage, 
trains of stimuli at 1, 2 and 4Hz) in the absence (A) and the presence
(B) Of a combination of the NA uptake blockers normetanephrine (NMN, 
10 °M) and desmethylimipramine (DMI, 10”%). E.j.p.s were not 
significantly affected by the presence of NMN and DMI, while the 
mechanical response was greatly enhanced (overall increase 72.6±9.4%, 
p<0.001, n=15). NMN and DMI together failed to uncover any secondary
electrical event associated with NA. Intracellular microelectrode 
recordings were made from the same cell.
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responsible for the rising phase of the action potential and hence 
blocks nerve conduction and subsequent pre-junctional release of 
excitatory substances. TTX (10"6M) abolished both the electrical and 
mechanical responses to field stimulation (0.5msec, supramaximal 
voltage, l-32Hz, Fig. 18), in the rabbit saphenous artery, confirming 
the neuronal origin of the putative transmitter substances.
(B) GUANETHIDINE
The adrenergic neurone blocking agent guanethidine (10“% )  also 
abolished both the electrical and mechanical responses to field 
stimulation (0.5msec, supramaximal voltage, l-32Hz, Fig. 19), 
suggesting that both ATP and NA were released from the same nerve in 
the rabbit saphenous artery.
(C) IDAZOXAN
The (X2 -adrenoceptor antagonist idazoxan (10“% )  produced significant 
increases in both the mean amplitude of the evoked e.j.p.s (p<0.05) 
and the mean mechanical response (p<0.001) to field stimulation 
(0.5msec, supramaximal voltage, l-8Hz, Fig. 20). 50% of the increased
mechanical response was blocked by addition of prazosin (10 % ) ,  while 
a combination of prazosin (10-% )  and a|3 MeATP (10 % )  abolished both 
the enhanced e.j.p.s and mechanical response. This implies that 
c^-adrenoceptors on the pre-junctional nerve terminal modulate both NA 
and ATP release, suggesting once again, that NA and ATP are 
co-released from the same nerve.
2Hz
B Field stim. (•) in tetrodotoxin 10 %
4Hz
TUT
8Hz
+
1Hz 2Hz 4Hz 8Hz
Fig. 18. The effect in the rabbit saphenous artery of tetrodotoxin 
(TTX, 10”%,  B) on the electrical (upper trace) and mechanical 
responses to field stimulation (•, 0.5msec, supramaximal voltage, 
l-8Hz). All electrical responses were abolished, suggesting a neuronal 
origin for the transmitter substances. Intracellular microelectrode 
recordings were made from the same cell. Total number of cells from 
which recordings were made (n) = 15.
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Fig. 19. The effect in the rabbit saphenous artery of the adrenergic 
neurone blocking agent guanethidine (10“% ,  B) on the electrical (upper 
trace in each case) and mechanical responses to field stimulation (•, 
0.5msec, supramaximal voltage, l-8Hz). Guanethidine abolished both the 
electrical and mechanical responses, suggesting that both the putative 
transmitters (NA and ATP) were released from adrenergic nerves. 
Intracellular microelectrode recordings were made from the same cell.
Total number of cells from which recordings were made (n) = 15.
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Fig. 20. Electrical (upper trace in each case) and mechanical 
responses of the rabbit saphenous artery to field stimulation (•, 
0.5msec, supramaximal voltage, trains of stimuli at 1, 2 and 4Hz) in 
the absence (A) and the presence (B) of the o^-adrenoceptor antagonist 
idazoxan (10”^M). Idazoxan increased both the mechanical and electrical 
responses, suggesting that o^-adrenoceptors control the pre-junctional 
release of both putative transmitters. Intracellular microelectrode 
recordings were made from the same cell. Overall, the mean i^ icrease in 
e.j.p. amplitude and contraction was 86.2±5% and 500±18%*l^<0*?o01, n=9)
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VIII. THE EFFECT OF EXOGENOUS ADDITION OF THE PUTATIVE TRANSMITTER 
SUBSTANCES
If NA and ATP are indeed co-transmitters in the rabbit saphenous 
artery (see Burnstock & Warland, 1987), then their exogenous addition 
to the artery should mimic the response obtained to field stimulation 
of intramural nerves. Thus if e.j.p.s are mediated by ATP, then 
exogenous application of the nucleotide should produce a comparable 
depolarisation. This should be absent when NA is added exogenously.
Application of ATP (lCT^M) by Picospritzer (40 p.s.i., 5-640msec, tip 
diameter lxl0“^m) produced a dose-dependent depolarisation of up to 
15mV, which resembled in shape and size, that produced in response to 
nerve stimulation. This depolarisation was blocked by a desensitising 
infusion of ap MeATP (10“6M), as were the evoked e.j.p.s (Fig. 21).
Responses to ap MeATP (10”^M) applied by Picospritzer (40 p.s.i.,
5-160msec, tip diameter lxlO-^), do not produce desensitisation
provided the time between individual applications of the drug exceeds 
lOmin. Applied in this manner, ap MeATP evokes dose-dependent
depolarisations, similar to those produced by ATP (Fig. 22). This
suggests that the effects observed with ATP are due to the nucleotide 
itself rather than one of its breakdown products. ap MeATP was some 
200 times more potent than ATP in depolarising the cell membrane.
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Fig. 21. Intracellularly-recorded electrical response to field 
stimulation (•, 0.5msec, supramaximal voltage, trains of stimuli at 
1Hz) and to ATP applied by close pressure ejection (o, 5-40ms)
in the absence (A) and the presence (B) of a continuous desensitising 
infusion of ap MeATP (10”^M). Both the e.j.p.s evoked by field 
stimulation and the depolarisation evoked by ATP were abolished by 
infusion of ap MeATP. Intracellular microelectrode recordings were made 
from the same cell. Total number of cells from which recordings were 
made (n) =12.
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Fig. 22. Intracellularly-recorded ^ electrical responses to doses of ap 
MeATP, applied by pressure ejection (o, 10~^M, 5-40ms). ap MeATP
produced a dose dependent depolarisation. Intracellular microelectrode 
recordings were taken from the same cell. Total number of cells from 
which recordings were made (n) = 9.
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Addition of NA (10~2M)by picospritzer (40 p.s.i., 5-640msec, tip 
diameter lxl0“^m) failed to alter the membrane potential, even in the 
presence of the NA uptake blocking agents NMN (10"6M) and DMI (10”6M) 
in combination (Fig. 23), confirming the absence of any 
noradrenergically mediated electrical event.
VIII. SUITABILITY OF ANTAGONISTS
(A) ap MeATP
Where purinergic substances have been proposed as co-transmitters, ap 
MeATP has been widely used to desensitise P2 X~purinoceptors and so 
antagonise contractile responses mediated by ATP. Recent doubts 
raised however regarding its selectivity for these receptors led to a 
re-examination of the actions of ap MeATP.
This was done in three series of experiments.
(1) The effect of a3 MeATP on the contractile responses to a variety 
of agonists.
To establish the selectivity of ap MeATP at P2 -purinoceptors, the 
effect of ap MeATP on a number of purinergic and non-purinergic 
agonists was examined.
Contractile responses to ATP (10“^-10“2M) and ap MeATP
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Fig. 23. Intracellularly-recorded electrical response to field 
stimulation (•, 0.5msec, supramaxijnal voltage, single stimuli) and to 
NA applied by close pressure ejection (o, 10”2M, 10-640ms) in the
absence (A) and the presence (B) of normetanephrine (NMN, 10“^M) and 
desmethylimipramine (DMI, 10"%!). NA produced no change in the membrane i 
potential even in the presence of the NA uptake blocking agents NMN and 
DMI. The presence of evoked e.j.p.s was used to confirm cell 
penetration. Intracellular microelectrode recordings were taken from 
the same cell. Total number of cells from which recordings were made 
(n) = 9.
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(10 °-10 *M) were each inhibited by a desensitising infusion of ap 
MeATP (10“^M, Fig. 24A). Contractile responses to NA (10”^-10“^M, Fig. 
24B), histamine ( K T 6-10“4M, Fig. 24C) and 5-HT (10"6-10“4M) were each 
however unaffected by infusion of ap MeATP (10“^M).
Contractile responses evoked by the depolarising agent KC1 (l-16x 
10”2M) presumably resulting from activation of voltage dependent 
calcium channels, were attenuated by constant desensitising infusion 
of apMeATP (10”^M). KC1 however also evokes pre-junctional release of 
excitatory substances, in addition to its post-junctional actions. To 
prevent this pre-junctional release of transmitters by KC1, adrenergic 
nerves were destroyed by pre-treatment in vitro of the tissues with 
6-OHDA (5x 10_4M, 2h) until no contraction was evoked by field
stimulation (0.5msec, supramaximal voltage, 8Hz). Subsequently, 
contractions evoked by KCl (1-16x 10“2M) and presumably due to the 
post-junctional effects of this compound, were unaffected by ap MeATP 
(10"6M, Fig. 24D).
(2) The effect of aP MeATP on the membrane depolarisation produced by 
KCl.
Since KCl acts to produce a contraction by a voltage dependent 
mechanism, any effect of ap MeATP on the associated depolarisation 
produced by KCl would be seen to be a non-receptor effect. Tissues 
were pre-treated with 6-OHDA (5xlO”4M) as before.
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Fig. 24. The effect of continuous desensitising infusion of ap 
MeATP (•“*£ 10"6M) on the mechanical responses to ap MeATP
(10-7-3xl0 M, A ) , NA (10“7-3xl0"5M, B) and histamine 
(10“6-3xlcr4M, C). The effect of infusion of ap MeATP on the
contractions to KCl ( 1-16x 10-2M, D) were examined after 
pre-treatment of the tissue with 6-OHDA in vitro for 2h to abolish 
any effect of pre-junctional release of transmitter. Each graph 
shows the mean (± s.e.m.); number of observations > 5. ap MeATP
infusion antagonised the contractions to bolus addition of ap MeATP 
compared with control (** p<0.001) but not those to NA, to
histamine, or KCl.
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Addition of KCl (10-1M) by picospritzer (40 p.s.i., 5-80msec, tip
diameter lxl0“^m), produced a dose dependent depolarisation of the 
membrane potential. No change in the depolarisation evoked by KCl was 
seen during infusion of ap MeATP (10“^M) sufficient to produce 
desensitisation of P2 “Purinoceptors as previously described (Fig. 25).
These results suggest the absence of any non-receptor mediated 
post-synaptic effect of ap MeATP and strengthens the view that it is 
specific for P2 X ~purinoceptors.
(3) The effect of ap MeATP on membrane potentials, electrotonic 
potentials and evoked e.j.p.s
Electrotonic potentials (2-45mV) in response to hyperpolarising 
currents (5-60V/cm), applied (for 5s) through extracellular plate 
electrodes, were recorded intracellularly in the recording partition 
of an Abe & Tomita (1968) bath, as previously described. E.j.p.s 
evoked by field stimulation (0.5msec, supramaximal voltage, 1Hz) of 
intramural nerves of the rabbit saphenous artery, were likewise 
recorded intracellularly and the effect of desensitising infusions of 
ap MeATP (10“7-4xl0_^M) on these parameters was measured.
There was no alteration in the amplitude of the induced electrotonic 
potential and therefore, by implication no alteration in membrane 
conductance and resistance in the presence of these doses of ap MeATP, 
while e.j.p.s evoked by trains of pulses were abolished (Fig. 26). 
This indicated a lack of non-selective membrane effect of ap MeATP in 
this tissue.
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A KCHO-’M
•59mV
•69mV
40ms 160ms80ms
B KCL 10-’M in o£MeATP 1Q-«M
-60mV
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Fig. 25. The effect of a desensitising infusion of a/3 MeATP (10“DM) on 
the intracellularly-recorded electrical response to micro-application 
of KC1 (o, 10_1M, 10-320msec (ms)), where any pre-junctional effects of 
KCl had been removed using in vitro pre-treatment with 6-OHDA 
(5xlO”^M). KCl produced a dose dependent depolarisation, which was 
unaffected by a(3 MeATP. Imtracellular microelectrode recordings were 
med from the same cell. Total numberof cells from which recordings were 
made (n) =10.
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Fig. 26. Membrane potential changes in response to hyperpolarising 
pulses (o, 10-80mA) and to field stimulation (•, 0.5msec, supramaximal 
voltage, trains of stimuli at 1Hz) in the absence (A) and the presence
(B) of a continuous infusion of a(3 MeATP (4xlO“^M). The evoked 
electrotonic potentials were unaffected by ap MeATP, while evoked 
e.j.p.s were abolished. Intracellular microelectrode recordings were 
taken from the same cell. Total number of cells from which recordings 
were made (n) = 9.
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(4) The recovery rate of evoked responses to field stimulation and 
ATP, on washout of a3 MeATP.
To establish that ap MeATP abolished both evoked e.j.p.s and the 
responses to exogenously added ATP, by acting on the same purinergic 
receptor, intracellular microelectrode recordings were used. The 
responses to these two types of stimulation in the absence, presence 
and on wash out of a desensitising infusion of a|3 MeATP were then 
compared.
ATP applied by Picospritzer (40 p.s.i., 20msec, tip diameter lxlO”^M) 
depolarised the artery, while field stimulation (0.5msec, supramaximal 
voltage, 1Hz), evoked e.j.p.s. Both responses were abolished in the 
presence of a desensitising infusion of a|3 MeATP (10-^M). The time 
course of recovery of the responses to both field stimulation and ATP, 
on wash out of ap MeATP was comparable in all cases examined (Fig. 
27), suggesting that ap MeATP had a similar effect on both neuronally 
released non-adrenergic transmitter and on exogenously added ATP and 
that these are likely to be acting on the same receptor.
ap MeATP does not show signs of any action, other than its ability to 
desensitise p2 -purinoceptors in the rabbit saphenous artery.
(B) SURAMIN
Dunn & Blakeley (1988), proposed that suramin also inhibited 
P 2 ~purinoceptors without antagonising noradrenergic receptors. The 
opportunity was therefore taken to examine the suitability of this 
drug in the rabbit saphenous artery as a purinergic antagonist.
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F'ig. 27. (A) The intracellularly-recorded electrical response to field 
stimulation (•, 0.5msec, supramaximal voltage, trains of stimuli at 
1Hz) and to ATP applied by pressure ejection (o, 10“% ,  20msec (ms))
compared to controls, during recovery from a desensitising infusion of 
a|3 MeATP (10”6M) plotted against time (min). (B) A characteristic and 
typical intracellular recording of the response to the aforementioned 
stimuli during and on washout of ap MeATP. Both the evoked e.j.p.s and 
the depolarisation to ATP were abolished by ap MeATP. The recovery rate 
of these two parameters on washout of ap MeATP was not significantly 
different. Intracellular microelectrode recordings were taken from the 
same cell. Total number of cells from which recordings were made (n)
=9.
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Suramin alone produced no change in membrane potential, nor any 
contraction.
Contractions to ap MeATP (10“^-10“% ,  Fig. 28A), ATP (10“^-10“% )  and 
field stimulation (0.5msec, supramaximal voltage, l-16Hz) recorded 
from ring preparations were antagonised by constant infusion of 
suramin (10“% ) .  Contractions to NA (10”^-10“% ,  Fig. 28B), were 
unaffected, as were the post-junctionally evoked contractions to 
KCl(1-16x10“% ,  Fig. 28D). Any pre-junctional release of transmitter 
substances by KCl, was abolished by pre-treatment in vitro with 6-OHDA 
(5xl0“% )  to destroy adrenergic nerves, as previously described. 
Contractions to histamine (10“^-10“% ,  Fig. 28C) and to 5-HT 
(10"6M-10“5M), were however attenuated by suramin (10“% ) .
Intracellular electrical and simultaneous mechanical recordings 
showed that suramin (10“% )  abolished the evoked e.j.p.s and reduced 
by approximately 50%, the mechanical response to field stimulation 
(0.5msec, supramaximal voltage, l-16Hz, Fig. 29). The residual
_r7
mechanical response was abolished by prazosin (10 'M).
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Fig. 28. The effect in the rabbit saphenous artery of infusion of 
suramin (10”^M) on the contractile responses to ap MeATP (10“^-10“^M, 
A ) , NA C) and histamine "(10“^-3xl0“^M), (each plotted as g
tension). The effect of suramin on contractions evoked by KCl 
(l-16xlO“^M, D, plotted as percentage maximum response), were examined 
after pre-junctional release of transmitter had been prevented by in 
vitro treatment of the tissue with 6-OHDA (5xlO“4M). Each graph shows 
the mean (± s.e.m.); number of observations > 5. Suramin attenuated the 
responses to both ap MeATP and histamine (** P<0.05, *** P<0.001), but 
did not alter the contractions to NA or to the post-junctional effects 
of KCl.
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Fig. 29. Intracellularly recorded electrical (upper trace in each 
case) and mechanical responses to field stimulation (•, 0.5msec, 
supramaximal voltage, trains of stimuli at 1, 2, 4 and 8Hz) in the 
presence of prazosin (10”^M, B) alone and together with suramin (10”^M, 
C), compared with control (A). Suramin abolished the electrical 
response and any residual mechanical response left by treatment with 
prazosin alone. Intracellular microelectrode recordings were taken from 
three different cells. Total number of cells from which recordings were 
made (n) = 15.
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IX. THE BIOCHEMICAL BASIS FOR THE CONTRACTION TO AGONISTS.
(A) NORADRENALINE
(1) Phosphatidylinositol bisphosphate (PIPp) hydrolysis
Hydrolysis of PIP2 has been associated with contraction in a number 
of vascular tissues (see Introduction). Its importance in the rabbit 
saphenous artery and rat tail artery was assessed by measurement of 
incorporation of [3H]inositol into total inositol phosphates (tIPs), 
in response to NA.
In the rabbit saphenous artery, NA (10”7-10“^M) failed to raise the 
levels of tIPs, even in the presence of propranolol (3xlO”^M), to 
inhibit any negative effect of NA on PIP2 hydrolysis via 
p-adrenoceptors (see Hall & Hill, 1988).
In the rat tail artery, here used as a positive control, NA 
(10-7-10-^M) increased in a dose-dependent manner, levels of tIPs 
produced by hydrolysis of PIP2 * The maximum increase was at 10“^M NA 
and was of the order of a ten fold increase over control levels (Fig. 
30). The increase in tIPs produced by NA was abolished by prazosin 
(10“6M), indicating that NA acts in the rat tail artery but not in the 
rabbit saphenous artery, to produce PI?2 hydrolysis via 
o^- adrenoceptors.
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Fig 30. The effect of increasing doses of noradrenaline (NA) 
(10“^-10”^M) on accumulation of total [^H]-inositol phosphates 
(tip), measured as disintegrations per minute (d.p.m.) per mg of 
tissue (wet weight), in rat tail (o) and rabbit saphenous (Q) 
arteries pre-incubated with myo-[^H]-inositol, compared with drug 
free controls. Number of observations > 9 in each case. NA evoked 
a dose dependent rise in tIP in the rat tail (*** P<0.001) but not 
in the rabbit saphenous arteries.
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(2) The effect of PMA.
The phorbol ester PMA (10“®-10_7M ) , is reported to stimulate protein 
kinase C by a mechanism analogous to that of diacylglycerol 
(Nishizuka, 1983).
In ring segments of rabbit saphenous artery, PMA increased the 
contractile response to field stimulation (0.5msec, supramaximal 
voltage, l-32Hz, Fig. 31A) and NA (10"7-10"5M, Fig. 31B). The 
contractile response to KCl (10“2-1.6xlO“^M, Fig. 31C), where 
pre-treatment of the artery in vitro with 6-OHDA had been carried out 
as previously described, was unaffected by pre-treatment with PMA.
This indicated that protein kinase C activation potentiated - the 
receptor-mediated contractile response to NA in the rabbit saphenous 
artery.
(3) The effect of staurosporine.
The antibiotic staurosporine (10“9-10“7M ) , which inhibits a number of 
protein kinases, including protein kinase C (Riiegg et a l ., 1989), did 
not attenuate the contractile responses of the rabbit saphenous artery 
to NA (10"7-10"5M, Fig. 32A), nor did it alter contractions to KCl 
(10"2-1.6xl0_1M, Fig. 32B), in tissues which had been pre-treated with
6-OHDA as before.
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Fig. 31. The effect of the phorbol ester, phorbol 1,2-myristate 
1,3-acetate (PMA, 10“7-10'‘®M) on the contractions of the rabbit 
saphenous artery to field stimulation (0.5msec, supramaximal voltage,
1-64HZ, A) and NA (10_7-10"4M, B). The effect of PMA on KCl
(1-16x10 2M, C) was investigated after pre-treatment with 6-OHDA 
(5x10 4M) in vitro had been carried out as before. Each graph shows the 
mean [± s.e.m.); number of observations > 5. The responses to both NA 
(>10 M) and field stimulation (2 1Hz) were significantly enhanced by 
the presence of PMA (P<0.001). The contractions to KCl were however 
unaffected, suggesting that PKC potentiates the receptor-mediated 
contraction to NA.
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Fig. 32 The effect of staurosporine (10”^-10 ®M) on the 
contractions of the rabbit saphenous artery to NA (10”^-10“^M, A) 
and KCl (1-16x10"2M, B). In the case of KCl pre-treatment with 
6-OHDA (5x 10“4M) in vitro had been carried out to abolish any 
pre-junctional release of transmitter substances. Each graph shows 
the mean (± s.e.m.); number of observations > 5. Neither the
contractions to NA or to KCl were altered by the presence of 
staurosporine.
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(4) The effect of mepacrine.
The involvement of phospholipase A2 (PLA2 ) in the mechanical response 
to NA was assessed using mepacrine, which is known to inhibit this 
phospholipase. (Lindmar et al., 1986)
Mepacrine (3x 10“3m) no^ alter the response of ring segments of
rabbit saphenous artery to NA (10”^-10-4M, Fig. 33), implying that 
PLA2 is not an enzyme involved in the contraction to NA in this 
tissue.
(5) The effect of sodium oleate (NaOl) and sodium fluoride (NaF). 
While these drugs may have additional actions, NaOl and NaF can
respectively stimulate (Hattori & Kanfer, 1984) and inhibit (Bocckino 
et al., 1987) phospholipase D (PLD). They were therefore used as an 
indicator of the possible involvement of PLD in the .contraction to NA 
in the rabbit saphenous artery.
In ring segments of artery, NaOl (2xlO”^M) enhanced (Fig. 34A) and 
NaF (5x 10~3M) inhibited (Fig. 34B) the mechanical response to NA 
(10~^-10_4M ) , giving some indication that PLD may indeed be involved 
in the mechanical response to NA in this tissue.
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Fig. 33. The failure of mepacrine (3x10“% ) ,  which inhibits 
phospholipase &2' attenuate the contractions of the rabbit
saphenous artery to NA (10*~^-10_^M). Each graph shows the mean (± 
s.e.m.); number of observations > 5 ;  *** p< 0.001.
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Fig. 34. Contraction of the rabbit saphenous artery to NA 
(10”^-10”^M) in the presence of sodium oleate (NaOl,
A) and sodium fluoride (NaF, 5x10 ^-10 ^M, B), each alone, which 
may respectively enhance and inhibit, phospholipase D. Each graph 
shows the mean (± s.e.m.); number of observations > 5. NaOl
increased (*** p<0.001)and NaF reduced (* p<0.05, ** p<0.01, ***
p<0.001) the contractions evoked by NA in this tissue.
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(6) Phosphatidylcholine (PC) hydrolysis.
PC hydrolysis leads via different phospholipases (see introduction), 
to glycerophosphocholine (GPC, via PLA2 ), choline (Cho, via PLD) and 
to phosphocholine (ChoP, via PLC). Measurement of changes in the 
levels of these metabolites can be used to give an estimation of the 
involvement of PC hydrolysis in the contractile response to agonists.
Stimulation of the rabbit saphenous artery with NA (10“^-10-^M) 
evoked a rapid, dose dependent rise in levels of Cho and ChoP but not 
of GPC (measured 30s after addition, Fig. 35). The absence of any 
change in the levels of GPC suggest that PLA2 is not involved in this 
response, confirming the previously observed inability of mepacrine to 
alter the contraction evoked by NA in ring segments of artery.
Analysis in the time course for changes in Cho and ChoP levels (Fig. 
36) in response to NA (10“^m) showed an large initial fast rise (after 
15-30s) in Cho, accompanied by a smaller rise in ChoP, consistent with 
the onset of the contractile response to NA seen in ring segments of 
artery. This suggests that PLD and, to a lesser extent, PLC are acting 
to catalyse the hydrolysis of PC in this tissue. The suggestion that 
PLD is a part of the response is in keeping with the results 
previously obtained using NaOl and NaF.
Subsequent to the initial rise, Cho levels were not maintained, but 
returned to basal levels within l-2min. By contrast the initial rise 
in ChoP were followed by a larger, later rise (at 2-4min). This may 
result from phosphorylation of the earlier
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Fig. 35. The effect, measured after 30s, of increasing doses of NA 
(10“^-10“^M) on the release of [*^H]-choline (Cho) and [^H]-choline 
phosphate (ChoP) in rabbit saphenous arteries, pre incubated with 
[^H]-choline chloride. NA evoked a dose dependent rise in the 
levels of both Cho and ChoP, (*p<0.05, *** p<0.001) measured as 
disintegrations per minute (d.p.m.) per mg tissue (wet weight).
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Fig. 36. (A) Time dependent changes in the levels of. [H]-choline 
(Cho) and [^H]-choline phosphate (ChoP) measured as disintegrations per 
minute (d.p.fti.) per mg tissue (wet weight), in response to NA (10-5M, 
number of observation (n) > 9). There was an initial (15-30s) large 
rise in Cho, accompanied during the same period, by a smaller rise in 
iChoP. A larger, much later rise was seen in ChoP at 2-4min. (B) The 
effect of increasing doses of NA on changes in tension (g wt.) the
time to reach maximum contraction corresponds with the initial rise in 
Cho and ChoP observed in Fig 36 (A).
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evoked Cho by choline kinase, as has been postulated for the 
recycling of phosphatidyl choline, or from further actions of a PLC. 
Both the evoked rise in Cho and ChoP was abolished by pre-incubation 
of the artery with prazosin (10“^M).
The ability of NA to stimulate a rise in levels of Cho and ChoP 
suggest that hydrolysis of phosphatidylcholine by PLD and PLC but not 
PLA2  may be a mechanism by which NA, acting on a-adrenoceptors, 
mediates contraction in the rabbit saphenous artery.
(B) NON-ADRENERGIC AGONISTS
(1) PIP2 hydrolysis
The effects of ap MeATP, histamine and KCl on incorporation of [^ |] 
inositol into total inositol phosphates (tIPs) was examine, to 
establish whether the inability of NA to evoke hydrolysis of PIP^ was 
unique to the noradrenergic co-transmitter, or in fact indicated a 
general absence, in the rabbit saphenous artery, of the mechanism for 
this hydrolysis.
The slowly hydrolysable compound ap MeATP was used to indicate the 
responses evoked by ATP; the putative co-transmitter in this artery. 
Histamine was used as an alternative example of a compound which 
evokes a receptor-operated contraction and KCl as a mediator of a 
voltage-operated, receptor-independent contraction.
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In contrast to noradrenaline's apparent inability to hydrolyse -PIP2 
and hence evoke a rise in total inositol phosphate levels, both ap 
MeATP (10-6M; ED80 for contraction) and histamine (3xlO“6M; ED80 for 
contraction) significantly raised tIP content of the rabbit saphenous 
artery (Fig. 37). This suggests that the mechanism for receptor 
activated hydrolysis of PIP2 exists in this artery and can be utilised 
by agonists other than NA, including the putative co-transmitter ATP.
By contrast, addition to tissues treated in vitro with 6-OHDA in the 
manner previously described, of KCl (8xlO_2M; ED80 for contraction), a 
compound which evokes a depolarisation and contraction, presumably by 
activation of voltage-dependent calcium channels, did not elicit any 
alteration in levels of tIPs (Fig. 37). This suggests that the 
hydrolysis of PIP2  evoked by, for example ap MeATP, is not a direct 
consequence of depolarisation, or of raised calcium levels, but that 
PIP2 hydrolysis is likely to result from receptor occupation by some 
agonists.
(2) PC hydrolysis
The ability of other agonist, including the putative co-transmitter 
ATP, to evoke PC hydrolysis was examined in the rabbit saphenous 
artery. As before, ap MeATP was used to indicate responses evoked by 
ATP.
In a manner analogous to that seen with NA, ap MeATP (10 ^-10 ^M) 
evoked a dose dependent rise in levels of both Cho and ChoP in
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Fig. 37. The effect of NA (10"5M), ap MeATP (10"6M), histamine 
(3x 10“6M) and KCl (8xlO"2M) on the accumulation of total 
[2H]-inositol phosphates (tIP, number of observations (n) > 9 in 
each case), measured as disintegrations per minute (d.p.m.) per mg 
of tissue (wet weight), in rabbit saphenous arteries pre-incubated 
with myo-[2H]-inositol. While NA and KCl were each ineffective, ap 
MeATP and histamine each evoked a significant rise in tIP levels 
(** p< 0.005).
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the rabbit saphenous artery (Fig. 38A). Levels of GPC were.not 
altered at any dose of ap MeATP used.
Histamine (10 ^-10 ^M) similarly evoked a dose dependent increase in 
both Cho and ChoP, in the absence of any change in GPC (Fig. 38B), 
suggesting that histamine likewise stimulated PC hydrolysis.
The analysis of the time dependency of generation of Cho and ChoP in 
response to ap MeATP (10"5M, Fig 39A) and histamine (10'5M, Fig 39B) 
showed that, as with NA induced stimulation, early rises in both Cho 
and ChoP were evoked by each of these agonists. ChoP levels showed a 
biphasic pattern, similar to that seen with NA, however Cho levels did 
not significantly decline over the period observed.
The initially evoked rise in ChoP in response to ap MeATP was 
approximately equivalent to that of Cho, suggesting that ap MeATP can 
stimulate hydrolysis of PC, with equal dependence on both PLD and PLC.
In contrast, levels of ChoP evoked by histamine (10“^M, Fig 39B). 
were substantially higher than the rise in levels of Cho, suggesting 
the predominant involvement of PLC in the response to histamine in the 
rabbit saphenous artery. The rise in levels of both Cho and ChoP 
evoked by histamine were well maintained throughout the period 
examined, perhaps reflecting the more prolonged contraction observed 
in response to this agonist, compared to NA.
These results suggest that a number of agonists evoke contraction in 
the rabbit saphenous artery by stimulating the hydrolysis of
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Fig. 38. The effect, measured after 30s, of increasing doses of 
ap MeATP (10_7-10_4M, A) and histamine (10_7-10_4M, B) on the 
release of [H]-choline (Cho) and [^H]-choline phosphate (ChoP) in 
rabbit saphenous arteries, pre-incubated with [^H]-methyl choline 
chloride (number of observations (n) > 9). Histamine and ap MeATP 
each evoked a rise in levels of both Cho and ChoP, (* p<0.05, ** 
p<0.005, *** p<0.001) measured as degradations per minute (d.p.m.) 
per mg tissue (wet weight).
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Fig. 39. Time dependent changes in the levels of [ H]-choline 
(Cho) and [^H]-choline phosphate (ChoP) measured as disintegrations 
per minute (d.p.m.) per mg tissue (wet weight), in response to ap 
MeATP (10 M, A) and histamine (10"5M, B) (number of observations 
(n) > 9 ) .  ap MeATP evoked an initial rise at 15-30s in levels of 
both Cho and ChoP, with the rise in ChoP being proportionally 
slightly greater. A larger, later rise in ChoP was observed at
2-4min. Histamine evoked a large rise in ChoP, accompanied by a 
smaller rise in Cho. The increased levels of both Cho and ChoP 
evoked by histamine were maintained during the period investigated.
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PC. The extent however, to which PLD and PLC are utilised in the 
hydrolysis of this phospholipid, varies. In addition, while NA 
stimulates the hydrolysis of PC in the absence of any action on PIP2 ' 
other agonists, including the putative co-transmitter ATP, may act to 
produce contraction by stimulation of a combination of these 
mechanisms.
(C) THE EFFECT OF CO-TRANSMISSION ON THE HYDROLYSIS OF PC
The effects on hydrolysis of phosphatidylcholine (PC) of NA and a(3 
MeATP added singly and in combination were examined to investigate any 
synergism that may exist between the putative co-transmitters at this 
level.
Addition of NA (10”^-10“^M) and a(3MeATP (10“^-10”^M) alone and in 
combination (10_^-10_^M using matched concentrations in each case), 
evoked dose dependent increases in Cho (Fig. 40A) and ChoP (Fig. 40B). 
Comparison of equimolar doses of these agonists showed that a|3 MeATP 
was more potent than NA evoking hydrolysis of PC.
The increase in Cho levels evoked by a(3 MeATP in conjunction with NA 
was not significantly greater than the response to a(3 MeATP alone. The 
increase in levels of ChoP evoked by a combination of a(3 MeATP and NA 
was however significantly larger than the response to either of the 
individual compounds. Within experimental limits this increase was 
approximately equal to the arithmetic combination of the individual 
response to NA and ap MeATP. There was no evidence of synergism.
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4 0 0 0 -
% 2000-
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Fig. 40. The effect, measured after 30s, of increasing doses of NA 
(10“^-10~^M), a|3 MeATP (10-6-10“4M) and a combination of matched
doses of NA ( K T 6-1CT4M) and ap MeATP (10”6-10"4M) on the release 
of [3H]-choline (Cho, A) and [3H]-choline phosphate (ChoP, B) in 
rabbit saphenous arteries, pre incubated with [3H]-choline 
chloride. The combination of NA and a/3 MeATP evoked a dose 
dependent rise in ChoP, which was significantly (p<0.05) greater 
than the rise evoked by either agonist alone, being approximately 
equivalent to the arithmetical sum of the individual responses but 
showed no evidence of synergism. The rise in Cho evoked by a 
combination of NA and a/3 MeATP was no greater than that seen with 
ap MeATP alone. Results were measured as disintegrations per minute 
(d.p.m.) per mg tissue (wet weight). Number of observations > 6.
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THE EFFECT OF ADENOSINE AND ADENOSINE ANALOGUES ON HEART RATE (HR) 
AND HIND LIMB PERFUSION PRESSURE (HLPP) IN THE DOG.
(A) POTENCY OF AGONISTS
To establish the subtypes of adenosine receptor mediating bradycardia 
and vasodilation in the dog, a potency order for adenosine analogues 
was first established.
Concentration-response curves for adenosine (0.001-0.3mg/Kg) and 
adenosine analogues N^-cyclopentyl adenosine (CPA, 0.001-0.3mg/Kg), 
r-N^-phenylisopropyl adenosine (r-PIA, 0.001-0.3mg/Kg), 2-phenylamino 
adenosine (PAA, 0.001-0.3mg/Kg) and 5 1-N-ethylcarboxamide adenosine 
(NECA, 0.0001-0.lmg/Kg) in canine heart are shown in Fig. 41A. With 
the exception of PAA, all agonists produced a dose dependent decrease 
in heart rate (HR, measured as beats per minute). PAA evoked a slight 
tachycardia. The order of potencies for decrease in heart rate was 
NECA > adenosine > CPA > r-PIA > PAA.
Concentration-response curves were also obtained for these agonists 
in the hind limb of the dog. Adenosine and all the adenosine analogues 
examined, produced a decrease in hind limb perfusion pressure (HLPP, 
measured as mmHg, Fig. 41B). The order of potencies for this, 
calculated from the ED^q values (shown in parenthesis) from the 
sigmoidal curve fits shown in Fig. 41B, was NECA, (0.001)> PAA, 
(0.0033)> adenosine, (0.025)> r-PIA, (0.05) = CPA, (0.055).
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Fig. 41. The effect of adenosine (0.001-0.3mg/Kg, number of 
observations (n) = 19), CPA (0.001-0.3mg/Kg, n=4), r-PIA
(0.001-0.3mg/Kg, n=l), PAA (0.001-0.3mg/Kg, n=2) and NECA 
(0.0001-0.lmg/Kg, n=l) on (A) heart rate (HR), measured as beats 
per minute (b.p.m.) and (B) hind limb perfusion pressure (HLPP) 
measured as mmHg, in the unconscious in vivo dog. The order of 
potencies derived for heart rate was NECA > adenosine > CPA > r-PIA 
> PAA and for hind limb perfusion pressure, was NECA > PAA > 
adenosine > r-PIA = CPA>
O ------- O adenosine
• — •  PAA
A --- A CPA
A------ ▲ NECA
□ ------ □  r-PIA
A.
O -------O Adenosine
"  • ------ •  PAA
.. A --- A CPA
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(B) THE EFFECT OF ANTAGONISTS
Antagonist potency was assessed by the dose required to produce a 
two-fold rightward shift of the adenosine dose response curve (DR2).
(1) Theophylline.
Dose-response curves to adenosine for both HR (Fig. 42A) and HLPP 
(Fig. 42B) were shifted to the right in a dose dependent manner by 
theophylline (l-10mg/Kg). The slope of the curve was not significantly 
altered in each case, suggesting a competitive antagonism. 
Theophylline was relatively non-selective however; the DR2 for heart 
rate was 3.46mg/Kg, while for HLPP the DR2 was 0.73mg/Kg, indicating 
only a small degree of selectivity for the adenosine receptor in the 
femoral arterial bed.
(2) PD116948
Where adenosine was added as a bolus injection into the left 
ventricle, the induced decrease in heart rate was inhibited in a dose 
dependent manner by the A^-selective antagonist PD116948 (0.3-3mg/Kg), 
with a DR2 of 0.4mg/Kg (Fig. 43A), while the reduction in HLPP (Fig. 
43B) produced by adenosine was antagonised by PD116948 with a DR2 of 
0.9mg/Kg. This suggests that, rather surprisingly, PD116948 is 
relatively non-selective for the adenosine receptors mediating 
bradycardia in the dog heart and femoral
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Fig. 42. The effect of theophylline (l-10mg/Kg) on the changes 
evoked by adenosine (0.001-lmg/Kg) of (A) heart rate (HR) measured 
as beats per minute (b.p.m.) and (B) hind limb perfusion pressure 
(HLPP) measured as mmHg, in the unconscious in vivo dog. Number of 
observations (n) = 3. The dose response curves for both HR and
HLPP to adenosine, were shifted to the right in a relatively 
non-selective, dose dependent manner by theophylline.
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Fig 43. The effect of PD116948 (0.3-3mg/Kg) on the dose response
curves to bolus addition of adenosine (0.001-lmg/Kg) for (A) heart 
rate (HR) measured as beats per minute (b.p.m.) and (B) hind limb 
perfusion pressure (HLPP) measured as mmHg, in the unconscious in 
vivo dog. Number of observation (n) = 3. The adenosine dose
response curves for both HR and HLPP, were shifted to the right in 
a relatively non-selective, dose dependent manner by PD116948.
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arterial bed.
In a single experiment, adenosine was added by infusion into the left 
ventricle (Fig. 44). On this occasion, PD116948 produced an average 
inhibition 3.1 fold greater than that seen with the same dose under 
conditions of bolus addition. HLPP could not be measured in this 
experiment since infusion of adenosine produced marked desensitisation 
in the hind limb.
The possibility exists that lack of full receptor occupation may 
explain the apparent lack of selectivity of this antagonist in the 
dog. A greater sample number would be required however before any 
conclusions could be properly drawn from this result.
(3) PD115199.
The adenosine induced changes in HR (Fig. 45A) and HLPP (Fig. 45B),
were both attenuated in a dose dependent manner by the selective A 2
antagonist PD115199 (0.3-3mg/Kg). The DR2 for HLPP was 0.034mg/Kg, 
compared with 1.37mg/Kg for HR, indicating that PD115199 was some 40 
fold selective as an antagonist of HLPP compared to HR.
The effects of PD116948 and PD115199 each alone, on the response to
the relatively A 2 selective agonist CPA were investigated.
PD116948(lmg/Kg) produced very little shift of the dose response 
curve to CPA in either the heart (Fig. 46A) or the hind limb (Fig.
A 
He
ar
t 
ra
te 
(b
.p
.m
.)
pg.156
90 
80 
70 
60 
50 
40 
50 
20 
10 
0
0.010 _ 0.100 1.000
[Adenosine] (m g/Kg)
O control
•  +  PD116948 0.3mg/Kg
Fig. 44. The effect of PD116948 (0.3mg/Kg) on the dose response
curves to addition of adenosine (0.01-lmg/Kg) by infusion into the 
left ventricle for heart rate (HR), measured as beats per minute 
(b.p.m.) in the unconscious in vivo dog. Number of observations (n) 
= 1. PD116948 produced an average inhibition of the response to 
adenosine, which was more than 3 fold greater than that observed 
with bolus addition.
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Fig. 45. The effect of PD115199 (0.3-3mg/Kg) on the dose response 
curves to bolus addition of adenosine (0.001-lmg/Kg) for (A) heart 
rate (HR) measured as beats per minute (b.p.m.) and (B) hind limb 
perfusion pressure (HLPP) measured as mmHg, in the unconscious in 
vivo dog. Number of observations (n) = 3. The adenosine dose
response curves for both HR and HLPP, were shifted to the right by 
PD115199. The DR2 for HLPP was 0.034mg/Kg/ compared with a DR2 of 
1.37mg/Kg, indicating a selectivity of 40:1 for HLPP : HR.
pg.158
A.
801  —
O — o control
70  "  •  •  +  PD116948 1 mg/Kg
6Q ^  A + PD115199 0.3mg/Kg
5 0 -
« 4 0 -
o
cm
t  3 0 -o0)
<  20-
04=
0.001 0.010 0.100
B
70
O o control
•  •  +  PD116948 1 mg/Kg
A  A +PD115199 0.3mg/Kg
6 0 -
5 0 -
4 0 -
CT
X
E
E
3 0 -
20 -CL
Q._1
X
<
- 1 0 4 —
0.001 0.010 0.100
[CPA] (mg/Kg)
Fig. 46. The effect of PD116948 (lmg/Kg) and PD115199 (0.3mg/Kg) 
each alone, on the dose response curves to CPA (0.001-lmg/Kg) for 
(A) heart rate (HR) measured as beats per minute (b.p.m.) and (B) 
hind limb perfusion pressure (HLPP) measured as mmHg. Number of 
observation (n) = 2. PD116948 showed little selectivity between the
two parameters measured. PD115199 however produced a significant 
attenuation of the hind limb response in the absence of any effect 
on the heart rate response to CPA.
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46B). PD115199 (0.3mg/Kg) likewise did not alter the response to CPA
in the heart (Fig. 46A), but produced a significant attenuation of the
HLPP (Fig. 46B). These results suggest that any lack of selectivity
H8*
exhibited by PD116948^unlikely to be the result of a mixed receptor 
population in the heart.
DISCUSSION
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CO-TRANSMISSION IN ARTERIAL SMOOTH MUSCLE
In response to the substantial amount of evidence presented over the 
last 50 years, our understanding of nerve transmission has been 
greatly altered and widened, to incorporate co-existence, co-release 
and co-transmission of a variety of biologically active compounds in 
the fine control of muscle by nerves.
Co-existence - the anatomical co-localization of more than one 
transmitter substance in peripheral and central neurones, is a 
widespread phenomenon. Co-release has been demonstrated in a large 
number of examples, but perhaps the most important control mechanism 
for cells is that of co-transmission.
Understanding the mechanisms by which multiple co-transmitters act or 
interact in a single target cell in vitro is important if the role of 
co-transmitters in the whole animal is to be understood. Previous 
studies have commonly measured only the contractile response as a 
means by which to study co-transmitters, with the inherent problems of 
interpretation that this method involves. This study therefore sought 
to examine in greater detail, the mechanisms underlying the 
contraction. The results outlined in this thesis can accordingly be 
discussed under three categories;
1) Those arising from investigation of the electrical properties of 
the transmitter by the use of intracellular microelectrode and 
simultaneous mechanical recording techniques. These techniques allow 
for a degree of separation of the component parts of co-transmission
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as well as giving an indication of the degree of importance of 
voltage-dependent mechanisms in the actions of each putative 
transmitter.
2) Those obtained using biochemical measurements, intended to 
determine the receptor mediated transduction systems utilised by the 
transmitters.
3) Those obtained from an in vivo investigation of purine (adenosine) 
receptors in the dog heart and hind limb, obtained from experiments 
carried out in ICI laboratories.
Electrical and simultaneous mechanical recordings.
The rabbit saphenous artery was chosen for this study, it being a 
well innervated vascular preparation, which had been previously shown, 
by mechanical means, to exhibit co-transmission by NA and ATP 
(Burnstock & Warland, 1987) or a related compound. This artery was 
easily accessible for dissection, gave reproducible, maintained 
results and by spiralling one end of the artery for attachment to a 
force displacement transducer, allowed simultaneous mechanical and 
electrical recordings to be made. Intracellular microelectrode studies 
showed the mean resting membrane potential of the rabbit saphenous 
artery (-69mV) to be similar to that seen in other vascular smooth 
muscles, e.g. guinea-pig mesenteric artery (-69mV, Ito et al, 1983) 
and rabbit ear artery (-67mV, Surprenant, 1980). On the basis that the 
resting membrane potentials were represented by a uniform population, 
there was no evidence of there being more than one population of cells 
in this study. The space constant (^) was relatively short (0.42mm),
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comparable with that seen in, for example, rat tail artery (0.41mm, 
Cassell et al., 1988, see also Holman & Surprenant, 1979) and
consistent with the circular orientation of the smooth muscle (Holman 
& Surprenant, 1979) bundles.
The electrical and simultaneous mechanical results provide strong 
evidence for co-transmission involving NA and ATP, or a related 
substance, in the rabbit saphenous artery. There is little doubt that 
the origin of the transmitters producing these responses was neuronal, 
since electrical and mechanical events were abolished in the presence 
of tetrodotoxin (TTX), which abolishes the increase in sodium 
permeability underlying the nerve action potential. Similarly, all
O  _i_
electrical and mechanical events were abolished by removal of Ca^ 
from the Krebs solution; calcium being required for transmitter 
release from nerves. In addition, the transmitter substances released 
were likely to have originated from the same adrenergic nerves, rather 
than from separate adrenergic and purinergic nerves, since the 
adrenergic neurone blocking agent guanethidine abolished all 
electrical and mechanical responses. In addition, the c^-adrenoceptor 
antagonist idazoxan potentiated both the electrical and mechanical 
response, suggesting the presence of ql^ -adrenoceptors which control 
the release of the two transmitters..
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Pharmacological evidence confirmed that the transmitters involved in 
the response to field stimulation in the rabbit saphenous artery were 
noradrenaline (NA) and ATP, or a related substance. This conclusion 
was supported by the observation that the mechanical and electrical 
responses to each component could be separated by the use of 
antagonists. Thus NA appeared to mediate a part of the contraction, 
but did not evoke any electrical event, as shown by the ability of the 
a 2 ~adrenoceptor antagonist prazosin to abolish some 50% of the 
contraction. This antagonism occurred in the absence of any effect on 
membrane potential or on the evoked e.j.p.s, even in the presence of 
normetanephrine and desmethylimipramine to block both neuronal and 
non-neuronal uptake of NA. ATP (or a closely related substance) on 
the other hand was responsible for the entire electrical event 
(e.j.p.s) as well as the remainder of the contraction, as evidenced by 
the actions of the P2 X-purinoceptor desensitising agent a|3 MeATP'. This 
pattern of co-transmitter responses was similar to that seen in the 
rabbit mesenteric artery (Lim et a l ., 1986). The suggestion that ATP 
mediated the evoked e.j.p.s was further strengthened by the ability of 
both a(3 MeATP and ATP, applied by close pressure ejection, to mimic 
the electrical response to nerve stimulation, while, even in the 
presence of normetanephrine and desmethylimipramine, NA failed to 
evoke a depolarisation when applied in this manner.
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The e.j.p.s mediated by the co-transmitter ATP, were unusually
'peaky' in shape (c/f Holman & Surprenant, 1979) and were associated 
with contractions. E.j.p.s did not however summate to produce action 
potentials, in the absence of the potassium channel blocking agent
tetraethylammonium (TEA). This is in contrast with other arterial
smooth muscles where summation of e.j.p.s reaches the threshold
required for action potentials, e.g. rat tail artery (Cassell et al.,
1988), rabbit ear and guinea-pig mesenteric arteries (Surprenant, 
1980). The lack of action potentials in the absence of TEA resembles 
the situation in the rat anococcygeus (Creed et al., 1975) and bovine 
retractor penis (Byrne & Muir, 1984) muscles, where field stimulation 
likewise produced e.j.p.s associated with contractions while action 
potentials were initiated in the presence of TEA.
In the rabbit saphenous artery, it seems likely that the upstroke of
the action potential evoked in the presence of TEA is carried by
calcium current, since these action potentials were abolished by 
diltiazem which inhibits voltage dependent calcium channels (Beattie 
et al., 1986).
The question remains as to whether, in the rabbit saphenous artery, 
TEA unmasks a calcium current which is normally present, but cannot be 
observed under control conditions, or whether this calcium current is 
normally absent. The unusual shape of the e.j.p.s would perhaps 
indicate the presence of 'truncated' action potentials, suggesting 
that the former explanation is more plausible. Further studies, 
perhaps using patch clamp techniques would be necessary to confirm 
this. It seems unlikely however that the e.j.p.s alone account for the 
contraction, since a calcium component of the e.j.p.s was not unmasked
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by the presence of the calcium antagonist diltiazem. This lack of 
calcium current assosciated with e.j.p.s was in contrast with the 
situation seen in other arteries, such as the rabbit ear artery 
(Benham & Ts*\e.,n, 1987), where ATP activates channels with a degree of 
selectivity for Ca^+ over Na+ .
The results with TEA suggest that there is a rectifying potassium 
current which under control conditions 'aborts' the action potential 
upstroke. Where however the method of Abe & Tomita (1968) was used to 
assess the passive membrane properties of the rabbit saphenous artery, 
the amplitude of the electrotonic potential evoked in this technique 
was linearly proportional to the stimulus intensity. Thus no 
rectification was observed over the stimulation parameters used. This 
may however reflect an inability to sufficiently depolarise the cell 
membrane using this technique and hence demonstrate this phenomenon 
(see Holman & Surprenant 1979).
The reduction in the amplitude of the e.j.p.s following reduction or 
removal of Na+ or K+ , together with the evidence from the use of TEA, 
suggests that each of these ions may contribute to the evoked response 
in this artery. Doubling [K+ ]Q produced a membrane depolarisation as 
expected. This may explain the reduced amplitude of the e.j.p.s and 
the potentiated mechanical response. The absence of any significant 
change in the membrane potential when the tissue is exposed to K+ free 
Krebs was however unexpected. This may reflect a similar mechanism to 
that found in the guinea-pig taenia coli, where it was proposed 
(Casteels, 1970) that although K+ free Krebs solution increased K+ 
permeability, resulting in a decrease in intracellular K
The unexpected depolarisation in response to a decrease in [Na+ ]Q may 
have resulted from a number of factors. Since Cl- uptake into smooth 
muscle may be driven by the Na'+ gradient (Brading, 1979; 1980), any 
reduction in Na4- might evoke a decrease in [Cl- ]^, resulting in 
depolarisation. The possibility however that Choline chloride, used to 
substitute for NaCl, produces a membrane effect cannot be discounted 
(Lim, 1985).
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concentration, this was offset by an accompanying increase in 
intracellular Na+ ions, so negating any hyperpolarisation
The ability of Cl withdrawal to reduce or abolish e.j.p.s may be due 
to its effect on Na+ conductance and the Na+/K+ ATPase pump.
The experimental evidence supporting both the role of ATP as the 
transmitter responsible for the e.j.p.s and the conclusion that ATP is 
acting via P2 x -purinoceptors, relies heavily on the use of the ATP 
analogue a,(3-Methylene ATP (a(3 MeATP) to selectively desensitise 
P 2 x -purinoceptors. As previously described however, there have been a 
number of criticisms of this compound.
The foregoing results suggest however that a(3 MeATP is a suitable 
selective agent for the study of ATP as a co-transmitter in the rabbit 
saphenous artery.
In support, a(3 MeATP did not alter the responses, either mechanical 
or electrical to the non-purinergic agonists used, irrespective of 
whether these responses were mediated via receptors, e.g. 
5-hydroxytryptamine (5-HT), histamine and noradrenaline (NA) or via 
KC1 operated, voltage-dependent channels. These results support the 
view that a(3 MeATP was selective for purinoceptors.
In contrast to the situation seen in the chicken rectum (Komori et 
al., 1988), constant infusion of a(3 MeATP in the rabbit saphenous
artery resulted in an initial depolarisation which quickly declined, 
leaving no residual depolarisation. Subsequently, changes in membrane 
conductance and resistance evoked by square wave hyperpolarising 
currents were unaffected by the presence of this drug. This implies
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the lack of a non-selective membrane effect of a(3 MeATP. Similarly, 
there was no difference in the rate at which the smooth muscle of the 
rabbit saphenous artery regained responsiveness to exogenously added 
ATP, or to neuronally released transmitter (e.j.p.s), on washout of a(3 
MeATP. This suggests that this drug is acting similarly on those areas 
utilised by both the neuronal transmitter and exogenous ATP, i.e. 
purinoceptors.
These results demonstrate that a(3 MeATP is a suitable agent for 
blocking the actions of ATP in this tissue.
The alternative antagonist examined in the present study was suramin. 
This was found to be less suitable than a(3 MeATP as an antagonist of 
P 2 X~purinoceptors in the rabbit saphenous artery.
Purinoceptors were antagonised by suramin in the absence of an effect 
on adrenoceptors. There did not appear to be any non-selective, 
non-receptor mediated effect of this compound, since the 
post-junctionally mediated contractions to KCl were likewise 
unaffected by suramin. In contrast to a(3 MeATP however, suramin 
attenuated the responses to some non-purinergic agonists, namely 5-HT 
and histamine, which may reflect suramin’s ability to bind to a large 
number of proteins (Wills & Wormall, 1950). This relative 
non-selectivity of suramin for purinoceptors, makes it unsuitable for 
further use in the study of ATP as a co-transmitter in the rabbit 
saphenous artery. Since it shows some affinity for purinoceptors, 
suramin may however provide a starting point for the development of 
more selective P2 ~purinoceptor antagonists. Suramin has also been 
shown to inhibit the ectonucleotidases responsible for breakdown of
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ATP (Hourani & Chown 1989) and this may be reflected in the large 
doses (10”% )  required to block purinoceptors. It is therefore 
possible that any use suramin may have in the study of co-transmission 
will lie in the development of analogues which potentiate the effects 
of ATP by inhibiting its breakdown.
The apparent inability of NA to produce an electrical event either 
when released during field stimulation, or on exogenous addition is in 
contrast to the situation in a number of other vascular tissues. Thus 
for example, NA released by neural stimulation produces e.j.p.s and 
action potentials in the guinea-pig pulmonary artery (Suzuki, 1983)
and guinea-pig submucosal arteries (Hirst, 1977). In other tissues, 
e.g. rabbit ear artery (Allcorn et al., 1985), nerve released NA is 
responsible for only the small slow depolarisation following the main 
electrical event (e.j-P*)* This latter event may be mediated by 
another putative transmitter. In addition, exogenously added NA can 
produce depolarisation in a large number of tissues, e.g. rat
mesenteric (Mulvany et al., 1982) and guinea-pig ear artery (Kajiwara
et al., 1981). In the rabbit saphenous artery, as in the rabbit
pulmonary artery (Casteels et al,, 1977), NA acting via 
a-adrenoceptors, does not significantly alter the membrane potential
and may act to produce a contraction via voltage-independent 
mechanisms.
The possibility cannot however be discounted that voltage changes 
occur in response to NA in the rabbit saphenous artery, but that they 
cannot be measured by the current technique. Using patch clamp 
techniques, Amedee et a l . (1990) showed that in the rabbit ear artery,
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NA elicited mixed inward and outward currents. The possibility cannot 
be excluded that in the rabbit saphenous artery, NA evokes equivalent 
inward and outward currents which result in a net absence of change in 
membrane potential. This remains to be investigated in this tissue.
There is some controversy regarding the ability of NA to act via 
voltage-independent mechanisms. Notwithstanding direct evidence for a 
stimulatory action of NA on phosphatidylinositol 4,5-bisphosphate 
(PIP2 ) hydrolysis (see introduction), some authors have proposed that 
NA contracts arteries solely by activating voltage-dependent Ca^+ 
channels, e.g. in rabbit mesenteric artery (Nelson et al., 1988). 
Other authors have however proposed an action of NA on receptor 
operated Ca^+ channels (Bolton & Large, 1986). It seems likely, in 
view of the conflicting evidence, that NA can act via a variety of 
mechanisms, depending on the tissue involved and the stimulation 
parameters.
From examination of the effects of ATP and NA on the membrane 
potential of the rabbit saphenous artery, it would appear that these 
co-transmitters act via different mechanisms to evoke contractions. NA 
appears to act solely via voltage-independent mechanisms in this 
tissue, while ATP clearly evokes voltage-dependent mechanisms to 
produce e.j.p.s associated with a contraction.
The fact that ATP produces a depolarisation in this tissue, does not 
however exclude the possibility that ATP also evokes second-messenger 
mediated transduction mechanisms, in the production of contraction. 
Indeed ATP has been shown to stimulate phosphatidylinositol 
4,5-bisphosphate (PIP2 ) hydrolysis in the rat tail artery (Jenkinson,
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1990), in addition to producing e.j.p.s.
The foregoing results, obtained by biochemical measurements, give 
evidence of the mechanism by which NA may act in the rabbit saphenous 
artery and suggest that both NA and ATP can evoke production of 
second-messengers in this tissue.
Biochemical Recordings.
The rabbit saphenous artery was found to be suitable for the study of 
biochemical pathways, by reason of its robust nature; necessary for 
the long incubations required to reach isotopic equilibrium during 
some of these experiments. In addition, this artery was available in 
suitable quantities for examination. The rabbit saphenous artery is a 
resistance vessel, likely to be representative of others involved in 
vascular tone.
Since a number of vascular smooth muscle preparations (see 
introduction) had previously been shown to act via hydrolysis of 
phosphatidylinositol 4,5-bisphosphate (PIP2 ), it seemed natural to 
examine the involvement of this pathway in the production of 
contraction in the rabbit saphenous artery.
It was clear however from the results obtained that, in the rabbit 
saphenous artery, NA did not stimulate PIP2  hydrolysis, as measured by 
incorporation of myo[^H]-inositol into the water soluble metabolites
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of this hydrolysis - the inositol phosphates. This is in contrast to 
the situation in, for example, the rabbit mesenteric artery - an 
artery which exhibits a similar pattern of co-transmission in terms of 
electrical and mechanical events, i.e. the electrical response is 
mediated by the non-adrenergic component alone, while the contraction 
is mediated by NA and ATP (Lim et Al., 1986). In the rabbit 
mesenteric artery, exogenously added NA enhances the breakdown of PIP2 
(Hashimoto et al., 1986).
This result was therefore rather surprising and a number of possible 
explanations were sought.
The lack of ability of NA to evoke PIP2  hydrolysis in the rabbit 
saphenous artery was shown not to be the result of 0 2-adrenoceptor 
stimulation mediating a negative effect on PIP2  hydrolysis, since 
pre-incubation with propranolol neither enhanced the contraction to NA 
nor evoked hydrolysis of PIP2 -
The possibility that the methodology used was in some way deficient 
was next considered, but no support for this was. evident. The rat 
tail artery, in which exogenous NA has been clearly shown to stimulate 
hydrolysis of PIP2  (Fox et al., 1985) was used as a positive control. 
By comparison with the rabbit saphenous artery, the rat tail evoked a 
dose dependent rise in inositol phosphates levels, confirming the 
validity of the method used.
A  third possibility was that the lack of PIP2  hydrolysis evoked by NA 
was the result of the characteristics of the particular ligand. The 
lack of hydrolysis of PIP2  in the rabbit saphenous artery was not due 
to the absence of the mechanism for this hydrolysis since histamine
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evoked a rise in inositol phosphates in this tissue, confirming 
similar observations in a number of tissues and cell lines (e.g. 
bovine tracheal smooth muscle, Hall & Hill, 1988).
More significantly, ap MeATP also evoked a rise in levels of inositol 
phosphates in the rabbit saphenous artery. a0MeATP was used as a 
stable analogue of the putative transmitter ATP, since ATP is rapidly 
degraded to adenosine by 5 1-nucleotidase and ATPase. Hence, of the two 
co-transmitters in the rabbit saphenous artery, NA does not produce a 
contraction via hydrolysis of PIP2 , while this hydrolysis may be a 
mechanisms by which ATP acts, in addition to activating 
voltage-operated channels (VOCs).
It is unlikely that the ATP stimulated PIP2  hydrolysis is simply 
consequential to Ca^+ entry, since KC1, which elevates [Ca^+ ]^ by 
opening voltage-dependent Ca^+ channels, did not stimulate PIP2  
hydrolysis in the rabbit saphenous artery.
With the widespread acceptance of PIP2 hydrolysis as a mechanism 
mediating contraction in a number of tissues, the ability of histamine 
and apMeATP to stimulate this hydrolysis is not perhaps unusual. PIP2  
hydrolysis has indeed been shown to be evoked by a large number of 
neurotransmitters and hormones (see Berridge, 1984). What is unusual 
is that NA, which has been shown to stimulate PIP2  hydrolysis via 
a-adrenoceptors in a number of tissues (see introduction), including 
other rabbit tissues, does not do so in the rabbit saphenous artery. 
The functional reasons for this are not yet known. Clearly however, 
PIP2  hydrolysis does not represent a mechanism shared by NA and ATP.
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The search for the voltage-independent mechanism underlying the 
contraction to NA, led to my investigating its effect on other 
membrane phospholipids in the rabbit saphenous artery.
Evidence that diacylglycerol (DAG) production, albeit not from PIP2  
hydrolysis and hence protein kinase C (PKC) activation was involved in 
the contractile response, came from the use of the phorbol ester, 
phorbol 1,2-myristate 1,3-acetate (PMA). PMA enhanced the contractile 
response to NA. It seemed likely that this was an effect mediated via 
a-adrenoceptors rather than an indirect effect on contraction, since 
contractions to KC1 were unaffected by PMA. The ability of phorbol 
esters to modulate a-adrenoceptor responsiveness, by their actions on 
protein kinase C has previously been shown (Cotecchia et al., 1985).
Staurosporine, which has been proposed to act by inhibiting protein 
kinase C (Tamaoki et al., 1986) did not attenuate the responses to 
either NA or KCl. Since however subsequent studies have suggested that 
staurosporine inhibits several protein kinases (Riiegg et al., 1989),
no firm conclusions can be drawn from this result.
An alternative source of DAG (see introduction) is from the 
hydrolysis of phosphatidylcholine (PC). This hydrolysis may be 
catalysed by number of phospholipases; by phospholipase C (PLC), 
leading to phosphocholine and diacylglycerol (DAG); by phospholipase D 
(PLD), producing choline and phosphatidic acid which is then 
metabolised to DAG; or by phospholipase A 2  (PLA2 ), producing a number 
of metabolites, including glycerophosphocholine (GPC) and ultimately 
DAG. The foregoing evidence suggests that in the rabbit saphenous 
artery, this hydrolysis is implicated in the contraction evoked by a
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number of agonists.
PC hydrolysis was estimated from changes in levels of the water 
soluble metabolites of the hydrolysis, choline (Cho), choline 
phosphate (ChoP) and glycerophosphocholine (GPC). NA evoked dose 
dependent rises in both Cho and ChoP, suggesting that NA evoked 
production of DAG by hydrolysis of this phospholipid and that this may 
be a mechanism by which NA evoked contraction in the rabbit saphenous 
artery.
This is the first time, to the best of my knowledge, that PC
hydrolysis has been implicated in the response to an agonist in smooth
muscle. Furthermore, although in cell lines, a number of agonists
have been shown to act via PC hydrolysis, the role of NA - an 
important neurotransmitter throughout the body - in the hydrolysis of 
PC has not before been established.
In the majority of examples so far studied, where PC hydrolysis in 
response to hormones and neurotransmitters exists, this has mostly 
occurred in conjunction with PIP2  hydrolysis. This led to much debate 
as to whether PC hydrolysis occurred as a consequence of PIP2
hydrolysis. Recently some cell lines have been demonstrated to exhibit 
PC hydrolysis in the absence of a 'PI response' (e.g. T lymphocytes, 
Rosoff et al., 1988), thus clearly separating these two phenomena. NA 
hydrolysis of PC in the rabbit saphenous artery would likewise appear 
to occur independently of PIP2  hydrolysis, confirming that these 
phenomenon are not necessarily linked. This mechanism of action of NA, 
via hydrolysis of PC in the absence of PIP2  hydrolysis, is very 
calcium sparing in that it does not require Ca^+ mobilisation either 
from intracellular or extracellular pools. Utilisation of PC
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hydrolysis as a source of DAG was shown not to be unique to NA in this 
tissue, since histamine and a(3 MeATP could similarly stimulate PC 
hydrolysis, thus both histamine and afJMeATP could each evoke 
hydrolysis of both PC and PIP2 -
Based on the observation that NA, histamine and a(3 MeATP each raised 
levels of Cho and ChoP but not GPC, it seemed likely that 
phospholipase D (PLD) and phospholipase C (PLC) but not phospholipase 
A 2  (PLA2 ) were implicated in the hydrolysis of PC in the rabbit 
saphenous artery (see Pelech & Vance, 1989). The inability of 
mepacrine, which inhibits PLA2 , to attenuate the mechanical response 
appeared to confirm the lack of activity of PLA2  in the contraction. 
The ability of sodium fluoride (NaF) to inhibit and sodium oleate 
(NaOl) to enhance the contraction to NA does not give unequivocal 
evidence of the involvement of PLD, however it perhaps strengthens the 
evidence that PLD is involved in the hydrolysis of PC in this tissue. 
The above evidence notwithstanding, the true nature of the 
phospholipases involved were better indicated by studying the time 
course of the hydrolysis.
NA does indeed evoke the activity of PLD, as evidenced by an initial 
large rise in Cho. In addition, PLC activity was also evoked by NA, 
since the rise in Cho was accompanied by a rise in ChoP. These rises 
correspond in time to the maximum contractile response to exogenously 
added NA. The rise in Cho was much greater than the rise in ChoP. This 
may reflect an ability of the smooth muscle of the rabbit saphenous 
artery to utilise PLD to a greater extent than PLC in producing 
contraction. The larger secondary rise in ChoP at around 2-4min, 
being well after the time for maximum contraction may result from a
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secondary activation of PLC, due perhaps to the actions of activated 
protein kinase C, but is perhaps more likely to be due to 
phosphorylation of the initially liberated choline. Phosphorylation of 
Cho by choline kinase, to ChoP has been proposed as part of the 
cyclical resynthesis of phosphatidylcholine (see Pelech & Vance,
1989). In the absence of a selective inhibitor of choline kinase, this 
study was unable to further investigate this secondary rise.
Histamine similarly evoked early rises in both Cho and ChoP, however 
these were more sustained than those seen with NA, perhaps reflecting 
the slower time course seen for contraction to histamine and the ratio 
of these metabolites differed. In the presence of histamine, the rise 
in ChoP was very much larger than the rise in Cho. This implies that 
in producing a contraction, histamine utilises predominantly PLC, with 
a smaller contribution from PLD.
A  slightly different pattern again was seen with af3 MeATP, which 
similarly evoked a rise in both Cho and ChoP. Although the maximum 
level of Cho obtained with a(3 MeATP exceeded the maximum level of 
ChoP, the rise in ChoP was proportionally similar, perhaps indicating 
an approximately equal reliance on the actions of both PLD and PLC.
Thus in the rabbit saphenous artery, PC hydrolysis would seem to be
evoked by a number of agonists, including both putative
co-transmitters. The possibility that this represented a level at 
which these co-transmitters interacted was addressed by examining the 
effect of a combination of NA and a(3 MeATP on levels of Cho and ChoP.
The foregoing results show that, while ATP and NA evoke an additive
effect, at least in terms of levels of ChoP evoked by a combination of
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these drugs, there was no evidence of synergism, the rise in ChoP 
being approximately equal to the sum of the response to each agonist
alone. The picture is less clear with Cho levels, however there is 
some evidence of an additive effect of these agonists at some doses 
used.
Although PC hydrolysis and hence presumably DAG production and 
protein kinase activation, is a level at which some interaction 
between NA and ATP can be shown, it is unlikely that this alone 
accounts for the additive effect of neuronally-evoked ATP and NA in 
producing a contraction in the rabbit saphenous artery. It would 
appear that NA evokes only one mechanism in the production of 
contraction, i.e. a rise in PC hydrolysis, while ATP uses a
combination of voltage-dependent and voltage-independent 
post-junctional mechanisms. ATP may open voltage-dependent Ca2+ 
channels and initiate Pl-phospholipase C mediated hydrolysis of PIP2  
-both mechanisms for increasing [Ca2+]^ - as well as evoking both
phospholipase D and PC-phospholipase C mediated hydrolysis of PC.
This, along with PIP2  hydrolysis, will produce DAG to stimulate 
protein kinase C and increase the sensitivity of the cell to existing 
levels of Ca2 + .
These mechanisms may act synergistically to produce the total 
response to ATP, however the possibility also exists that one or more 
of these mechanism may predominate during different levels of 
stimulation, perhaps as mechanisms to deal with stressful situations. 
Similarly, rather than producing independent components of the
contraction, ATP and NA may interact in a manner similar to that seen 
in hepatocytes and other cell lines (see introduction), where
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elevation of [Ca acts in addition to activation of protein kinase 
C to produce a maximum response.
In conclusion, the foregoing results suggest that in the rabbit 
saphenous NA evokes a voltage-independent contraction, mediated via 
the second messenger DAG. ATP on the other hand produces a contraction 
associated with e.j.p.s, which may evoke the subsequent opening of 
voltage-dependent Ca2+ channels. In addition, a component of the 
contraction evoked by ATP may be mediated by voltage-independent 
mechanisms. These mechanisms are likely to include both hydrolysis of 
PIP2  (leading to formation of the second messengers IP3 and DAG) and, 
in common with NA, hydrolysis of PC.
The question remains as to the functional significance of 
co-transmission in neurotransmission. In the rabbit saphenous artery, 
both transmitters play an approximately equal role in the production 
of contraction in vitro. This may simply reflect the gradual 
evolutionary change within neurones, from transmission with one 
transmitter, to transmission with another, conveniently observed in 
the rabbit saphenous artery at a midpoint in the transition. 
Alternatively, there may be a reason why two transmitters are 
advantageous to the functioning of this artery in vivo and perhaps the 
answer to this lies in the possibility of synergism between those 
mechanisms which directly raise intracellular Ca2+. and those which 
raise the sensitivity of protein kinase C to existing Ca2+ levels.
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Whatever the likely answer, physiologists and pharmacologists can no 
longer countenance the simplistic one neurone, one transmitter view of 
nerve transmission, but instead must view nervous control of muscle as 
a complex interaction of several transmitter substances, included 
among which are NA and ATP. In studying contraction in arterial 
smooth muscle, the degree of complexity of the system goes however 
beyond the number of transmitters released to encompass a complex 
arrangement of pre-and post-junctional receptors, coupled to a 
multiplicity of post-junctional mechanisms by which contraction is 
mediated. The possible requirements for the large number of pathways 
proposed, may lie in 'failsafe' mechanisms to cope with stressful 
conditions. How these interacting mechanisms, are altered in disease 
states, e.g. hypertension, has yet to be fully established and the 
role of PC hydrolysis in disorders of this nature has yet to be 
addressed. This may constitute interesting future research. Only by 
advances in our knowledge of the events occurring during normal 
nervous control of muscle will analysis of the nature of abnormalities 
occurring in disease states become more likely and the physiological 
role of co-transmitters better understood.
Once fully analysed, the multiple actions of co-transmitters may 
allow pharmacologists great scope for the development of new means to 
modify nerve control of muscle and to develop therapeutic regimes with 
a full understanding of the actions and targets of agents in the 
manipulation of co-transmitter systems.
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AN INVESTIGATION OF THE ADENOSINE RECEPTORS IN HEART AND VASCULATURE 
OF THE DOG
The foregoing results describe a research project undertaken in ICI, 
Alderley Edge, England, as part of the SERC CASE award requirement for 
industrial experience.
The complexity of our understanding of the actions of purines often 
lies in the number of subtypes of receptors which may exist to mediate 
drug effects. This work in the canine cardiovascular system, allowed 
examination of subtypes of the adenosine receptor and suggested that 
an atypical adenosine receptor may mediate bradycardia in the canine 
heart.
Hind limb perfusion pressure (HLPP) was used as a measure of 
vasodilator activity in resistance vessels. In a previous study 
(Belloni et a l , 1988), vasodilation was measured in the coronary 
vasculature. Clearly however, coronary output would effect 
measurements of this sort. Accordingly, in the present study, 
vasodilation in the hind limb was measured under conditions of 
constant flow; this being unaffected by changes in cardiac output.
By measuring the ability of adenosine and adenosine analogues to 
reduce HLPP, a rank order of potencies was obtained (NECA > PAA > 
adenosine > CPA = r-PIA, for abbreviations see methods), which was
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consistent with recognised criteria for an A 2  receptor subtype, in 
particular the A2a and was comparable with the results obtained for 
other vascular tissues, e.g. bovine coronary arteries (Mustafa & 
Askar, 1985) and guinea-pig aorta (Collis, 1985). Examination of the 
canine cardiac receptor mediating bradycardia, revealed however an 
order of potencies (NECA > adenosine > CPA > r-PIA > PAA), more in 
keeping with an A 2 j3 subtype, than the A^ type seen in other 
preparations, such as rat, guinea-pig and rabbit heart (Collis, 1985; 
Haleen & Evans, 1985). Thus, with the exception of the response to 
PAA, there was a similar order of potencies observed for adenosine 
analogues in reducing heart rate (HR) as in producing vasodilation. In 
addition, PD116948, which has been shown in other preparations to be 
A 2 selective, (see Collis et al, 1989) has less selectivity for
adenosine receptors in the in vivo dog preparation, than the
relatively non-selective adenosine antagonist theophylline, where 
adenosine is added by bolus injection. PD116948 had however, a much
greater antagonist effect against adenosine added by infusion,
implying that adenosine receptors are not saturated when a bolus 
addition is used. This however was examined during only one experiment 
and needs to examined further before strong conclusions can be made.
The possibility existed that the unusual order of potencies and the 
lack of selectivity of PD116948 was a result of a mixed A 2 /A2  
population in canine heart, especially since the A 2 selective agonist 
PAA could produce a positive chronotropic effect in heart. PD116948 
however produced only a small rightward shift of the dose response 
curve to the relatively A^-selective agonist CPA, which was not 
greater than the shift of the adenosine dose response curve produced
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by this antagonist. This implied that a mixed receptor population does 
not mediate the atypical responses to adenosine analogues in the 
canine heart.
The ability of both PAA and the A 2 selective antagonist PD115199 to 
distinguish clearly between the receptors in the hind limb, and in the 
heart, suggests that these receptors differ. The receptor in canine 
heart does however appear to be atypical and while the greater effect 
of PD116948 on the bradycardia evoked by adenosine infusion cannot be 
ignored, it appears nevertheless, that the adenosine receptor in the 
canine heart displays some of the characteristics of an A 2  receptor, 
as evidenced by the order of potencies of adenosine and adenosine 
analogues. It is however distinguishable from a A2a receptor on the 
basis of evidence from selective A 2  agonists and antagonists. The 
adenosine receptor in canine heart closely resembles the A ^  subtype 
proposed by Bruns et al. (1986;1987).
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